{
  "name" : "dacemirror.sci-hub.se_journal-article_c912aaf7212d27d36246b822627486d3_vargas2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : null,
    "authors" : [ "Kris G. Vargas", "Jelena Milic", "Asija Zaciragic Ke-xin", "Wen Loes Jaspers", "Jana Nano", "Klodian Dhana", "Wichor M. Bramer", "Bledar Kraja", "Ed van Beeck", "M.Arfan Ikram", "Taulant Muka", "Oscar H. Franco", "Ikram MArfan", "Muka Taulant", "Franco Oscar H.The", "Asija Zaciragic", "Ke-xin Wen", "Loes Jaspers", "M. Arfan Ikram" ],
    "emails" : [ "t.muka@erasmusmc.nl" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nTitle: The Functions of Estrogen Receptor Beta in the Female Brain: A Systematic Review\nAuthor: Kris G. Vargas Jelena Milic Asija Zaciragic Ke-xin Wen Loes Jaspers Jana Nano Klodian Dhana Wichor M. Bramer Bledar Kraja Ed van Beeck M.Arfan Ikram Taulant Muka Oscar H. Franco\nPII: S0378-5122(16)30122-0 DOI: http://dx.doi.org/doi:10.1016/j.maturitas.2016.05.014 Reference: MAT 6622\nTo appear in: Maturitas\nReceived date: 22-5-2016 Accepted date: 31-5-2016\nPlease cite this article as: Vargas Kris G, Milic Jelena, Zaciragic Asija, Wen Kexin, Jaspers Loes, Nano Jana, Dhana Klodian, Bramer Wichor M, Kraja Bledar, Beeck Ed van, Ikram MArfan, Muka Taulant, Franco Oscar H.The Functions of Estrogen Receptor Beta in the Female Brain: A Systematic Review.Maturitas http://dx.doi.org/10.1016/j.maturitas.2016.05.014\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\n1"
    }, {
      "heading" : "Highlights",
      "text" : " Forty-nine studies that investigated the functions of estrogen receptor beta (ERβ) in the female brain were included in this review. All included studies were performed in animal models.  Estrogen receptor beta phosphorylated and activated intracellular second messenger proteins, and regulated protein expression of genes involved in neurological functions. It also promoted neurogenesis, modulated the neuroendocrine regulation of stress response, conferred neuroprotection against ischemia and inflammation, and reduced anxiety- and depression-like behaviors.  The estrogen receptor beta agonist diarylpropionitrile (DPN) may induce a significant reduction of hippocampal ApoE mRNA and protein expression.  The results of the current systematic review show abundant functions of estrogen receptor beta in the female brain and support the notion that future therapies targeting estrogen receptor beta could constitute a novel preventive strategy and treatment for neurological diseases in females.\n2"
    }, {
      "heading" : "The Functions of Estrogen Receptor Beta in the Female Brain: A Systematic Review",
      "text" : ""
    }, {
      "heading" : "Kris G. Vargasa, Jelena Milic,a Asija Zaciragica, Ke-xin Wena, Loes Jaspersa, Jana Nanoa,",
      "text" : ""
    }, {
      "heading" : "Klodian Dhanaa, Wichor M. Bramerb, Bledar Krajaa,c,d, Ed van Beeck,e M. Arfan Ikrama,f,g,",
      "text" : ""
    }, {
      "heading" : "Taulant Mukaa,h, Oscar H. Francoa.",
      "text" : "a Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands b Medical Library, Erasmus MC, Rotterdam, The Netherlands c Department of Biomedical Sciences, Faculty of Medicine, University of Medicine, Tirana, Albania d University Clinic of Gastrohepatology, University Hospital Center Mother Teresa, Tirana, Albania e Department of Public Health, Erasmus University Medical Center, The Netherlands f Department of Neurology, Erasmus University Medical Center, The Netherlands g Department of Radiology, Erasmus University Medical Center, The Netherlands Short title: Estrogen receptor β in the female brain. hCorresponding author: Taulant Muka, MD, MSc, DSc., Department of Epidemiology, Erasmus University Medical Center, Dr. Molewaterplein 50, Office NA29-14, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Tel: +31 10 7043399. Email: t.muka@erasmusmc.nl\n3"
    }, {
      "heading" : "ABSTRACT",
      "text" : "Females have unique and additional risk factors for neurological disorders. Among classical estrogen receptors, estrogen receptor beta (ERβ) has been suggested as a therapeutic target. However, little is known about the role of ERβ in the female brain. Six electronic databases were searched for articles evaluating the role of ERβ in the female brain and the influence of age and menopause on ERβ function. After screening 3186 titles and abstracts, 49 articles were included in the review, all of which were animal studies. Of these, 19 focused on cellular signaling, 7 on neuroendocrine pathways, 8 on neurological disorders, 4 on neuroprotection and 19 on psychological and psychiatric outcomes (6 studies evaluated two or more outcomes). Our findings showed that ERβ phosphorylated and activated intracellular second messenger proteins and regulated protein expression of genes involved in neurological functions. It also promoted neurogenesis, modulated the neuroendocrine regulation of stress response, conferred neuroprotection against ischemia and inflammation, and reduced anxiety- and depression-like behaviors. Targeting ERβ may constitute a novel treatment for menopausal symptoms, including anxiety, depression, and neurological diseases. However, to establish potential therapeutic and preventive strategies targeting ERβ, future studies should be conducted in humans to further our understanding of the importance of ERβ in women’s mental and cognitive health. Keywords: estrogen receptor beta, neurological disorders, psychiatry, brain, menopause, systematic review\n4 1. INTRODUCTION Non-communicable diseases including neurological disorders constitute a significant and increasing public health problem [1]. The highest prevalence of many of the most common neurological disorders, including stroke, dementia, Parkinson’s disease, and depression are found in the female population [2]. Women are more prone to neurological disorders due to additional and unique risk factors: hypercoagulable states in relation to pregnancy and hormonal contraceptives, as well as longer lifespan predisposing women to Alzheimer’s disease (AD) and stroke [3]. In addition, postmenopausal women lose the protective anti-inflammatory effects previously conferred by estrogen, and replenishment of the hypoestrogenic state through hormonal replacement therapy seems to be insufficient.[3] Estrogen, including estradiol, has many physiological roles in the body and brain, all of which are mediated by its receptors. Estrogen receptor beta (ERβ) has multiple functions in the human body and has been found to be widely distributed throughout the brain [4, 5]. Consequently, high expression of ERβ in hippocampus, amygdala, and dorsal raphe nucleus has raised the question of whether these estrogenic receptors could be used as targets for novel therapeutic agents against common neurological and behavioral disorders [4]. However, the definitive role of ERβ and its mechanism of action in estradiol-regulated brain areas remain to be further elucidated. We conducted a systematic review of all the available evidence evaluating the function of ERβ in the female brain. 2. METHODS"
    }, {
      "heading" : "2.1 Literature Search",
      "text" : "This review was conducted using a predefined protocol in accordance with the PRISMA and MOOSE guidelines (Appendix A and B). Six electronic databases (Medline, Embase, Web of Science,\n5 PubMed, Cochrane and Google Scholar) were searched until September 17th 2015 (date last searched) without any language or study design restriction, with the help of an experienced medical information specialist (WMB). The search strategy combined terms related to exposure (e.g., estrogen receptor beta) and outcome (e.g., nervous system, mental function, depression, AD, Parkinson’s disease, cognition). In databases where a thesaurus was available (Embase and Medline), articles were searched by thesaurus terms and in title and / or abstract. In other databases, they were searched only by title and / or abstract. The full search strategies of all databases are provided in Appendix C. In total, we identified 3186 potentially relevant citations."
    }, {
      "heading" : "2.2 Study Selection and Inclusion Criteria",
      "text" : "We included studies that evaluated the function of ERβ in the female brain on at least one of the following outcomes: 1) cellular signaling, including metabolic regulation, regulation of gene expression in the brain, posttranslational modification, and neurogenesis; 2) neuroendocrine pathways, i.e., hypothalamic-pituitary-adrenal axis; 3) neurological outcomes, such as hippocampal-dependent learning tasks or memory; 4) neuroprotection, including protection against neuroinflammation, and finally; 5) psychological and psychiatric disorders including cognitive function, anxiety-related behavior, aggression, pain, emotions and sexual dysfunction, depression, AD and Parkinson’s disease. We considered studies that assessed the function of ERβ via its gene deletion, use of ERβ ligand, for example, diarylpropionitrile (DPN), antibodies/vectors or its expression levels. Studies performed either in female animals or adult humans were also included. We excluded conference abstracts, narrative reviews, studies evaluating the localization of ERβ only, as well as studies that assessed ERβ function in tissues other than the brain. Furthermore, we excluded studies that did not report the sex of participants or that did not show sex-specific results when both males and females were included.\n6 Two independent reviewers (KGV and AZ) screened the retrieved titles and abstracts and selected eligible studies. Any disagreements were discussed and resolved by consensus with the participation of a third investigator TM). Full texts were retrieved for studies that satisfied all selection criteria."
    }, {
      "heading" : "2.3 Data Extraction",
      "text" : "Two reviewers (KGV and AZ) independently performed the extraction of the data. A predesigned extraction form was used to collect relevant information from the selected full-text articles, including lead author, year of publication, sample type, sex, age, and number of participants, menopausal status, brain region involved, method used to assess ERβ function, outcome measures, and results of each study. In case of disagreement, a decision was made through consensus or consultation with a third independent reviewer (TM)."
    }, {
      "heading" : "2.4 Outcome Assessment",
      "text" : "For each animal study, we defined whether a positive (enhanced), negative (decreased), or null effect was reported. For population-based studies, we reported the effect magnitude, direction and significance. 3. RESULTS A total of 3186 potentially relevant citations were identified (Figure 1). After removing duplicates and excluding studies by titles and abstracts, 141 articles were retrieved for detailed assessment. Of these, 92 did not meet our selection criteria. Thus, 49 were included in our analysis."
    }, {
      "heading" : "3.1 General Characteristics of the Included Studies",
      "text" : "General characteristics of the included studies are reported in Table 1. All studies were performed in animal models (24 used tissues from mice, 24 from rats and 1 used combined tissue from both mice and rats). Of the included studies, 19 focused on the function of ERß on cellular signaling, 7 focused on the neuroendocrine pathway, 4 studied whether neuroprotection was conferred, 8 dealt with neurological\n7 outcomes and 19 with psychological and psychiatric outcomes. Six studies evaluated and reported results on two or more major outcomes [6-11]."
    }, {
      "heading" : "3.2 Cellular signaling:",
      "text" : "Nineteen studies evaluated the function of ERβ on cellular signaling (Table 2A). Of these, nine studies assessed the effect of phosphorylation in different subunits [9, 11-18]. Within these nine, four studies [11, 12, 15, 16] reported that activation of ERβ was associated with increased immunoreactivity and expression of phosphorylated mitogen-activated protein kinase (MAPK/ERK), protein kinase B (Akt), and tropomyosin receptor kinase B (TrKB) receptor. Also, one study [18] found that ERβ was involved in the phosphorylation of ERK1/2 in gonadotropin-releasing hormone (GnRH) neurons. Akt and TrkB receptors participate in synaptic plasticity involved in spatial memory, cognition, and other hippocampaldependant behaviors [16]. MAPK/ERK signaling regulates a variety of cellular activities including proliferation, differentiation, survival, and death and has been implicated in the development of AD, Parkinson’s Disease, and amyotrophic lateral sclerosis [19]. Two other studies [13, 14] showed that ERβ, via activation of metabotropic glutamate receptor (mGlur) 2 but not mGlur3, dephosphorylates Ltype calcium channels and, therefore causes a reduction in L-type calcium channel-mediated cAMP response element-binding protein (CREB). Furthermore, two studies [17, 18] reported an involvement of ERβ in CREB phosphorylation in GnRH neurons whereas another study [12] found regional actions of ERβ on CREB phosphorylation. In the medial preoptic septum, phosphorylation of CREB was found to be dependent solely on ERß, whereas no role of this receptor on CREB phosphorylation was found in hypothalamic ventromedial nucleus, caudate-putamen, or retrosplenial granulate cortex. Moreover, one study tested periodic ERβ-activation on CREB phosphorylation in the hippocampus and showed increased protein expression of phosphorylated CREB [9]. CREB has been found to be involved in the formation of long-term memories, long-term potentiation, and in the development of drug addiction, physiological dependence and Huntington’s Disease [20-24].\n8 Three studies assessed the function of ERβ on neurogenesis [6, 25, 26]. The first two studies were performed in the hippocampus under normal conditions, and the third in the subventricular zone after an induced stroke injury. Their conclusions were consistent in that the number of newborn cells was significantly increased with the activation of ERβ, and therefore support a role of ERβ in neurogenesis. Five studies evaluated gene and protein expression [10, 27-30]. One study found that ERβ activation was required in order to potentiate mitochondrial function in the brain [27]. The second study found that ERβ agonist affected the expression of a specified set of genes (Iba1, Cd68, Cd11b and Cd18) that, in turn, affects neuronal control of microglia and complement expression.[28]. Two studies concluded that ERβ increased the regulation of post-synaptic PSD-95 and AMPA-type glutamate receptor subunit GluR1 [10, 29]. One study evaluated the effect of DPN on the modulation of N-methyl-D-aspartate (NMDA) receptor specific binding and found no modulating effect [31]. One other study concluded that DPN upregulated the expression of more than 16 neuroinflammatory genes, thus leading to suspicion that ERβ may be a target to supress regulatory functions of glial cells in the E2-deprived female brain and inflammatory diseases [30]. Finally, one study assessed whether DPN had an effect on the desensitization of serotonin 1A (5-HT1A) receptor signaling and on the plasma levels of oxytocin and adrenocorticotropic hormone (ACTH) and found no effect [7]."
    }, {
      "heading" : "3.3 Neuroendocrine Pathway Outcomes:",
      "text" : "Seven studies evaluated the functions of ERβ on neuroendocrine pathway outcomes (Table 2B). Of these, one study found that ERß agonist activates GnRH firing and increases gamma-aminobutyric acid (GABA) transmission and postsynaptic response in GnRH neurons [32]. Two studies evaluated the involvement of ERβ in modulation of hypothalamus-pituitary-adrenal (HPA) axis reactivity [8, 33]. The first study found that administration of DPN reduced adrenal\n9 corticosterone (CORT) and ACTH responses to restraint stress. Based on the observed findings, the authors concluded that ERβ may modulate HPA/neuroendocrine stress reactivity [8]. The second study found that ERβ isoforms had a positive effect on regulation of corticotropin-releasing hormone (CRH) promoter activity; indicating possible involvement of ERβ in the mechanisms of the stress response and HPA axis disorders pathogenesis [33]. Thus, it was inferred that ERβ might not play a role in central regulation of serotonin via receptor 5-HT1A by mediating ACTH release. The role of ERβ in the induction of progesterone receptors (PRs), which are critical for female sexual behaviour, was assessed in two studies [6, 34]. One study showed that ERβ activation in hypothalamic ventromedial nucleus averts the action of ERα in the induction of PRs [34], whereas one study reported that the ERβ agonist selective estrogen receptor modulator beta 2 (SERM-beta 2) dose-dependently increased PRs in the murine dorsal raphe nucleus but not in the hippocampus [6]. Finally, one study assessed the role of ERβ in the expression and function of T-type calcium channels (subtype Cav3.2) in the hypothalamus. The authors found that the effect of estradiol on Cav3.2 was dependent on ERβ as well as on ERα indicating involvement of ERβ in excitability of hypothalamic neurons; namely, the study has shown that E2-treatment increases Cav3.1 in the pituitary, but decreases Cav3.2 and Cav3.3 in an ERα dependant manner. [35]"
    }, {
      "heading" : "3.4 Neurological outcomes:",
      "text" : "Eight studies evaluated the function of ERβ on neurological outcomes (Table 2C). Of these, four investigated memory as their main outcome [9, 10, 36, 37]. One study demonstrated that ERβ in dorsal hippocampus, through activation of mGluR1 signaling, enhanced novel object recognition and object placement memory [36]. Another study [10] concluded that along with increased protein expression of the AMPA receptor (AMPAR) subunit GluR1 and PSD-95, ERβ activation induced morphological changes in hippocampal neurons, including increased dendritic branching and increased density of\n10\nmushroom-type spines. Furthermore, the same study showed that ERβ improved performance in\nhippocampus-dependent memory tasks. This finding implies that activation of ERβ could regulate\nhippocampal synaptic plasticity and improve hippocampus-dependent cognition [10]. Jacome at al. found\nthat ERβ activation increased recognition memory and altered the levels of monoamines (3-methoxy-4-\nhydroxyphenylglycol (MHPG) or the MHPG/norepinephrine (NE) ratio), dopamine’s metabolite\n(homovanillic acid (HVA)), and serotonin metabolite (5-hydroxyindole acetic acid (5-HIAA)) in several\nareas of the brain, including the prefrontal cortex, ventral hippocampus and dentate gyrus, but not in the\nstriatum or medial septum. This finding implies that ERβ may enhance recognition memory through\nalterations in monoaminergic containing systems primarily in the prefrontal cortex and hippocampus.[37].\nOne study assessed spatial learning, memory, and post-ischemic neuronal survival. It showed\nimprovement in all these outcomes when ERβ agonist (DPN) was given periodically [9].\nThe four other studies evaluated a neurological outcome based on gene regulation and protein expression\n[38-41]. The first investigated the role of ERβ in regulating gene transcription and learning in the\nhippocampus. It found a positive effect and concluded that ERβ might regulate transcription involved in\nmaintaining hippocampal function during aging.[38] The second study on gene and protein expression\ndemonstrated a decrease in apolipoprotein E (ApoE) mRNA protein expression (detrimental in AD) with\nthe use of DPN [39]. The third publication studied whether any changes were produced at the insulin-\ndegrading enzyme (IDE) level. IDE is an enzyme involved in the catabolism of amyloid beta (Aβ) protein\nin the brain and has been associated with the etiology and development of AD. The third publication\nfound that DPN significantly increased IDE in hippocampal neurons via activation of\nphosphatidylinositol 3-kinase (PI3-K) [40]. Finally, the fourth study sought to determine the efficacy of a\nSERM formulation in the regulation of early stages of AD. A nine-month dietary supplementation of β-\nSERM formulation was found to promote physical health, prolonged survival and improved spatial\n11\nrecognition memory. It also revealed attenuation of both Aβ deposition and plaque formation in AD mice\n[41]."
    }, {
      "heading" : "3.5 Neuroprotection outcomes:",
      "text" : "Four studies set out to determine the role of ERβ on neuroprotection (Table 2D). Three of these\nconsidered whether protection against ischemia was conferred either by way of DPN [9, 42] or WAY\n200070-3 [43]. Regardless of the ERβ agonist used, their results were all similar in that protection of\nneurons in caudate nucleus and hippocampus against global ischemia-induced death was conferred. The\nfourth study evaluated two outcomes: regulation of cerebral inflammatory cytokine and chemokine levels\nas well as regulation of the blood brain barrier permeability. The authors found a positive effect for both\nand concluded that ERβ may also confer protection against neuroinflammation [44]."
    }, {
      "heading" : "3.6 Psychological and psychiatric outcomes:",
      "text" : "Nineteen studies assessed the function of ERβ agonists or behavioural testing after gene deletion\nor a combination of both (Table 2E). Of these, three studies considered anxiety-like behavior as their\nmain outcome. The first evaluated anxiety-like behavior and measurement of brain serotonin and\ndopamine levels. It found enhanced anxiety and decreased concentrations of these neurotransmitters in the\nabsence of functional ERβ [45]. The second studied the contribution of estrogen receptors in modulation\nof anxiety and analyzed the effect of deleting ERβ gene in mice. Absence of this receptor was associated\nwith expression of anxiety disorders and with a reduced threshold for synaptic plasticity in the amygdala,\nsuggesting a role of ERβ in the processing of emotional behaviour [46]. The third study showed that S-\nenantiomer of diarylpropionitrile (S-DPN) reduced anxiety-like behavior and attenuated stress-induced\ncorticosterone (CORT) and ACTH in wild-type mice, but not in mice lacking the ERβ gene, suggesting\nanxiolytic effects mediated by ERβ [47].\n12\nSeven studies focused on depression-like behaviour [6, 11, 48-52]. The first [48] described that\nactivation of ERβ in the CA3 region of hippocampus induced by DPN slowed serotonin clearance via\nMAPK/ERK1/2 signaling and interactions with both TrKB and IGF-1 receptors whereas no role of\nPI3K/Akt signaling in mediating this effect was shown. These results show an antidepressant-like effect\nof ERβ agonist. Moreover, the other six studies used the widely used behavioural assays/tests, Porsolt\ntest or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].\nTwo other studies evaluated both anxiety- and depression-like behaviors simultaneously. They reached\nthe same conclusion in that both outcomes were decreased after the use of ERβ agonists [8, 53].\nFour studies focused on the role of ERβ in tryptophan hydroxylase (TPH) 1 mRNA expression, which is\ninvolved in the synthesis of serotonin. Three of these studies found that ERβ was associated with\nincreased expression of TPH1 [6, 50, 54]. A fourth study concluded that high TPH levels could be\nmaintained by using the selective ERβ agonist, LY3201) even after ovariectomy [55].\nTwo publications dealt with social recognition. [56, 57]. Both used gene deletion, social recognition\nparadigm tests, and behavioral analysis. Their results were similar: ERβ is necessary for social\ndiscrimination and modulation of social behaviour [56, 57].\nThree publications looked to study the role of ERβ on extinction recall, which is the process of learning\nnot to fear. Two of these authors concluded that DPN administration facilitated extinction memory\nconsolidation [58, 59]. However, one study found that fear generalization was increased via an effect on\nfear memory retrieval mechanisms through activation of ERβ [60].\n4. DISCUSSION\nThis review summarizes 49 studies published worldwide that investigate the functions of ERβ in the\nfemale brain. The studies suggest multiple functions of ERβ might contribute to a diversity of normal\nneurophysiologic functions (Figure 2). Our results support non-genomic actions of ERβ on the\n13\nphosphorylation status and activity of multiple different signalling pathways in the brain. ERβ may act in\nthe female brain through MAPK/ERK1/2 and PI3K/Akt signalling pathways and interactions of ERβ with\nTrkB and IGF-1R may facilitate activation of these kinases. Akt and TrkB are markers of hippocampal\nsynaptic plasticity [61]. Spenser-Segal et al have demonstrated that ERβ mediates the increase in pAkt-ir\nexpression after treatment with estradiol for 6 hours. The kinase pathways in the brain play a role in cell\ndifferentiation, survival, apoptosis, and cell proliferation among other functions, all of which might\ndetermine the initiation and progression of neurodegenerative disorders [16]. Also, ERβ interacts with\nmetabotropic glutamate receptors (mGluRs) signalling, which may depend upon caveolin proteins that are\nessential for the trafficking and clustering of signalling molecules [13]. Among mGluRs, ERβ may\nactivate cell membrane-localized mGluRs type 2 and 3. Their activation would lead to decreased\nconcentrations of cAMP and a reduction in PKA activity, which would, in turn, result in\ndephosphorylation of L-type calcium ion channels and a reduction of L-type calcium ion channel-\nmediated CREB phosphorylation. Phosphorylation of CREB in the medial septum, for example, is\nundoubtedly due to action of ERβ since it is the only estrogen receptor type expressed in that part of the\nbrain. Alternatively, other regions devoid of both ERα and ERβ, such as the caudate putamen or granulate\ncortex, do not show signs of CREB phosphorylation. CREB-mediated transcription has been described as\npromoting synapse formation and transmission in long-term memory and conferring protection against\nstriatal neuronal death. Both of these attributes may be used as rationale for potential therapeutic\ninterventions against Huntington’s disease [10, 62]. Accordingly, an alteration of CREB functioning has\nalso been associated with major depressive disorder, drug addiction and psychological dependence;\nconditions which may be better treated with a more thorough understanding of ERβ’s biological function\n[63, 64]. Similarly, mGluRs act as a second messenger in the signalling pathway that modulates synaptic\ntransmission and neuronal excitability, suggesting a potential therapeutic utility in AD, Parkinson disease,\nschizophrenia, anxiety and depression [65, 66]. Consequently, further research into these components\nmay prove to be potential opportunities for treatment for Huntington’s disease, AD, epilepsy, and trauma\n[67, 68].\n14\nThe selected studies in this review consistently showed that ERβ agonists increased hippocampal proteins\nPSD-95, synaptophysin and AMPA-receptor subunit GluR1, and dendritic branching and mushroom-type\nspines. Altogether, these effects of ERβ may suggest a role of this receptor in enhancing synaptic\nplasticity by persistent strengthening of synapses (long-term potentiation) and improving hippocampus-\ndependent memory and cognition . Further evidence in this systematic review demonstrates that mGluR1\nfrom the dorsal hippocampus interacts with other membrane components such as p42 ERK and Gq\nproteins to enhance novel object recognition and object placement memory consolidation. These may\nconstitute potential targets for treatment of memory impairment conditions. The effect of ERβ on object\nrecognition and object placement memory tasks, however, may only be exerted in certain regions of the\nbrain and in response to a dose-dependent administration of estradiol. In this regard, ERβ and its agonist\nDPN have been associated with alteration of the monoamines 3-methoxy-4-hydroxyphenylglycol\n(MHPG) and metabolites of dopamine and serotonin: homovanillic acid (HVA) and 5-hydroxyindole\nacetic acid, respectively. These findings were noted only in the prefrontal cortex and dentate gyrus but not\nin the striatum or medial septum. [37]. Although ERβ is present in many areas of the neocortex, it is\nhighly expressed in the hippocampus and frontal cortex, areas that are important for memory [69].\nERβ also plays a key role in neurogenesis. Three of the studies included in this systematic review show a\nconsistent effect of increased cell formation in the hippocampal dentate gyrus and subventricular zone [6,\n25, 26], a finding supported by results from previous studies in adult animal models. [70, 71]. These\nparticular areas of the brain are known to produce a high expression of ERβ, which may explain their\nunique function of producing newborn cells. Neurogenesis in the hippocampus promotes the formation of\nnew episodic memories and may even contribute to the therapeutic actions of antidepressant treatment\n[72]. Similarly, newly formed astrocytes from the subventricular zone could stimulate brain repair after\nischemic injury and may limit the extension of neurodegenerative changes and traumatic brain injuries\n[26]. However, the functional outcome of cell proliferation may become more important if we consider\nthe exclusive presence and potential action of ERβ in other cell types of the brain, such as neurons of the\n15\nparaventricular, suprachiasmatic, and tuberal hypothalamic nuclei, as well as the cerebellum and pineal\ngland [73].\nOther mechanisms of ERβ action have been described in the neuroendocrine system. The activation of the\nHPA axis normally responds to a stress stimulus and is controlled by neurons in the paraventricular\nnucleus of the hypothalamus, an area of the brain rich in ERβ mRNA. Part of this response involves the\naction of CRH whose promoter activity may be regulated by ERβ isoforms. Furthermore, ERβ may also\ndecrease stress-induced HPA activation through oxytocin neurons in the hypothalamus. ERβ and oxytocin\nare highly co-expressed in that part of the brain and both their actions may be mediated by CRH. Control\nof ERβ signalling may be better appreciated in the female population given that females are known to\nsecrete higher levels of glucocorticoid in response to stress than are their male counterparts. Thus,\ntargeting ERβ may be of benefit in the treatment of anorexia nervosa and depression, conditions\ncharacterized by dysregulation of the HPA axis [8, 33]. ERβ was also found to increase postsynaptic\nresponse of GnRH neurons and could therefore prove to be important in regulating ovulation, fertility,\nand maternal behaviour [32, 74]. However, the display of lordosis, another female sexual behaviour in\nmice, could not be attributed to ERβ. Its lack of relationship to ERβ was implied from the null effect on\nthe expression of progesterone receptors in the hypothalamic ventromedial nucleus [34]. The raphe\nnucleus, on the other hand, may respond to the ERβ agonist SERM Beta2 in a dose-dependent manner in\norder to increase progesterone receptor expression [6]. Another significant contribution of ERβ may be\nobserved in the hypothalamus by way of regulation of low voltage-activated (T-type) calcium channels\nthat participate in burst firing and neurotransmission. These phenomena, however, may also be dependent\non the co-expression of other estrogen receptors, including ERα [35].\nERβ has also gained particular interest in the prevention of AD. Several studies included in this\nsystematic review have shown that ERβ agonist DPN may induce a significant reduction of hippocampal\nApoE mRNA and protein expression, an established risk factor for late-onset AD. In an aging study\nsample with low estradiol level, ERβ may compensate to maintain hippocampal function, provided that\nestradiol level is increased [38, 39, 41]. Another mechanism may involve catabolism of Aβ by insulin-\n16\ndegrading enzyme (IDE). ERβ, in conjunction with the activation of PI3-K, may regulate the expression\nof this protease in normal and early-stage AD brains. IDE induction, which is reported also to respond\nrapidly to estradiol administration, may prove to be a target for prevention of AD [40]. Functional\nsignificance of ERβ is also supported by findings from clinical studies in which genetic variations of ERβ\nwere found to increase the risk of AD in women.[75]\nNeuroprotection has also been consistently reported in this systematic review. ERβ may reduce global\nischemia in the caudate nucleus and CA1 pyramidal layer by enhancing expression of estrogen-regulated\ngenes such as ApoE or bcl-2. Other proposed vehicles for neuroprotection are activation of CREB or\npreservation of mitochondrial function [9, 42]. As ischemic neuronal death is mainly caused by\nmitochondrial dysfunction disrupting calcium homeostasis and increasing oxidative stress, interest has\nincreased in studying the pathway by which ERβ may potentiate mitochondrial function [9, 27]. Although\nthe exact mechanism of action for this protective effect remains to be further explained, its potential\nbenefits may help prevent loss of synaptic transmission after cerebral ischemia as well as age-related\ndecline in cognition. Reducing neuroinflammation may also confer brain protection. A number of\ncytokines and chemokines (interleukins) including IL-1 β, IL-6 and IL-12p40 in the brain may be\nregulated by ERβ through alteration of the blood brain barrier. These findings may contribute to decrease\nproinflammatory cytokines commonly described in postmenopausal females and thought to induce\nsubclinical states of neurodegeneration and cognitive decline [76].\nThis systematic review also shows consistency in the role of ERβ in modulating estrogen signaling in the\nprocess of emotional behaviour [8, 33, 45-47] and other types of behaviour such as social recognition and\nextinction recall[56-58]. The use of ERβ knockout animal models and adapted behavioural tests were\nparticularly useful in determining its functional role. Studies in this review have demonstrated that\nanxiety-like behaviour was enhanced, while serotonin levels decreased, with the absence of functional\nERβ. These effects may be region-specific to the stria terminalis, preoptic area, hippocampus, and\npossibly the dorsal raphe nucleus. The reduction of other monoamines such dopamine and\ndihydroxyphenylacetate may also be associated with increased anxiety in the absence of ERβ. Similarly,\n17\nthe addition of ERβ specific agonist DPN was found to attenuate the levels of stress-induced CORT and\nACTH; which may contribute to decrease anxiety-like behaviours in different test settings. Furthermore,\nERβ may reduce not only anxiety but also depression-like behaviour, which may be mediated by genomic\neffects of ERβ in 5-hydroxytryptamine (5-HT) neurons of the dorsal raphe nucleus. This effect was\ndescribed after testing (e.g., the open field, elevated plus maze, and the forced swim test) (Benmansour et\nal., 2015; Donner and Handa 2009). ERβ activation may increase expression of SERT and thereby induce\nslower serotonin clearance.[48]. Consequently, the intersynaptic serotonin gaps would be present in\nhigher concentrations and would have more time to exert its antidepressant effect; further suggesting that\nERβ may promote an antidepressant-like effect.\nTo our knowledge, this is the first systematic review assessing the role of ERβ receptor in female brain,\nfollowing an a priori designed protocol with clearly defined inclusion and exclusion criteria. So far\nnarrative reviews have mainly focused on estrogen signalling not targeting specific functions of ERβ [4,\n73, 77, 78]. Contrary to our study, the above mentioned narrative reviews covered only limited areas of\nERβ brain functions. Some limitations of this review need to be considered. We included studies that\nwere highly heterogeneous with respect to input parameters, assumptions, and study design. Therefore,\nperforming a quantitative pooling of the data was unfeasible. Also, all the included studies used animal\ntissue and so caution should be taken in consideration when extrapolating the results of this review to\nhuman subjects. Finally, publication bias may be a concern, as with all systematic reviews. However, we\ntried to minimize the impact of publication bias by employing a thorough search strategy in six databases\nin which no restrictions were applied on language or time of publication. In addition, reference lists were\nchecked for further studies.\nOverall, the results of the current systematic review included only animal studies showing abundant\nfunctions of ERβ in the female brain and supporting the notion that future therapies targeting ERβ could\nconstitute a novel preventive and/or treatment strategy for neurological diseases in females. ERβ agonists\ncan mimic the actions of 17β-estradiol in the brain without causing other physiological responses\nmediated by other estrogen receptors. In view of the high burden of depressive disorders and\n18\nneurodegenerative disease and despite advances in their prevention and treatment, transfer of these novel\ntherapeutic venues on the field of neurological diseases could constitute a suitable alternative in the\nfuture. However, in order to establish potential therapeutic and preventive strategies targeting ERβ in the\nfemale brain, future studies in humans would first be required."
    }, {
      "heading" : "Contributors",
      "text" : "TM and OHF conceived the study.\nKGV, JM, AZ and TM designed and performed the literature review, designed the search strategy,\nscreened titles and abstracts, obtained full text, determined eligibility of articles, participated in data\nextraction, data synthesis/analysis, data interpretation, coordination and writing the manuscript.\nWMB designed and performed the literature review.\nK-xW, LJ, JN, KD and BK screened titles and abstracts.\nEvB and MAI participated in data interpretation and writing the manuscript.\nAll authors contributed to the critical revision of the manuscript.\nOHF participated in study design and drafting of the final manuscript.\nTM and OHF are guarantors.\nAll authors approved the final version.\nKGV and JM contributed equally."
    }, {
      "heading" : "Conflict of interest",
      "text" : "K-xW, LJ and TM received research support from Metagenics Inc. JM, AZ, JN, KD and BK have been\nfinancially supported by Erasmus Mundus Western Balkans (ERAWEB), a project funded by the\n19\nEuropean Commission. OHF received grants or research support from Metagenics Inc. KGV, WMB, EvB\nand MAI have nothing to disclose."
    }, {
      "heading" : "Funding",
      "text" : "This study was sponsored and funded by Metagenics Inc. Metagenics Inc. with the steering committee\nwas involved in study design; collection, analysis and interpretation of data; writing of the report; and\ndecision to submit for publication. The funder/sponsor did not have the ability to veto publication of study\nresults."
    }, {
      "heading" : "Provenance and peer review",
      "text" : "This article has undergone peer review."
    }, {
      "heading" : "Legend for Figure 1.",
      "text" : "Flowchart of studies investigating the function of estrogen receptor beta in the female brain\n26"
    }, {
      "heading" : "Legend for Figure 2",
      "text" : "Potential pathways for ERβ function in the female brain.\nApoE mRNA, Apolipoprotein E messenger RNA; HPA, hypothalamus-pituitary-adrenal; IDE,\ninsulin-degrading enzyme; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;\nNMDA, N-Methyl-D-aspartic acid; Akt, Protein kinase B; MAPK, Mitogen-activated protein\nkinase; ERK, extracellular signal-regulated kinases; CREB, c-AMP response-element binding\nprotein.\n29\nTissue Outcome\n30\n11 [42] C57BL/6J mice\n44 3 months of age\nDPN Caudate nucleus and dorsal hippocampus\nNeuroprotection\n12 [18] Mice ND 2–3 months Gene deletion, 17-ß-estradiol\nGnRH neurons from medial septum (MS) to the anterior hypothalamic area\nCellular signaling\n13 [56] Mice 89 3–5 months old\nGene deletion, social recognition paradigm (tests) and behavioral analysis. NA Psychological outcomes: social recognition and anxiety\n14 [57] Mice 88 3–4 months Gene deletion, social recognition paradigm (tests) and behavioral analysis. NA Psychological outcomes: binary social discrimination 15 [32] Mice ND 2–3 months of age DPN Estradiol Preoptic area (POA) and hypothalamus Neuroendocrine pathway: GnRH release\n16 [6] Mice ND ND SERM-beta1, SERM-beta2, E2, gene deletion, forced swim test (FST)\nDorsal raphe nuclei, dentate gyrus in hippocampus\n Psychological outcomes: mood, antidepressive effect.\n Neurogenesis 17 [50] Sprague–\nDawley rats ND ND DPN and behavioral testing Brainstem (dorsal raphe nuclei) Psychological outcomes: stress and anxiety-related behaviors\n18 [59] C57/BL6 mice\nND 3-5 months old\nDPN Infralimbic medial prefrontal cortex\nPsychological outcomes: fear extinction\n19 [14] Rat pups ND 1–2 day old rat pups\nDPN Striatal neurons culture Cellular signaling: CREB phosphorylation\n20 [54] Mice ND 14 weeks Gene deletion, estradiol\nDorsal raphe nucleus (DRN) in midbrain.\nPsychological outcomes: serotonin\n21 [38] Mice 163 4 months and 13–14 months Gene deletion; Estradiol (17 ß-estradiol benzoate); Behavioral studies\nHippocampus Neurological outcomes: maintenance of hippocampal-dependent memory.\n22 [45] Mice 80 10 week Gene deletion;E2; behavioral testing (the elevated plus-maze test), monoamine HPLC\nCingulate cortex, caudate putamen, nucleus accumbens, medial septum, stria terminalis, hippocampus; posterodorsal amygdale; Psychological outcomes: modulation of estrogen effects on anxiety and catecholamine concentrations\n31\nsubstantia nigra; dorsal raphe, locus coeruleus\n23 [27] Sprague– Dawley rats\nND 4–6 months old\nDPN, E2\nIsolated brain mitochondria (of forebrain)\nCellular signaling: modulation of mitochondrial function in the brain\n24 [37] Sprague– Dawley rats\n32– 34 2 months old DPN; estradiol benzoate; behavioral tests (object recognition / placement memory tasks)\nNA Neurological outcomes: mediation of sub-chronic and acute effects of estrogens on recognition memory\n25 [46] Mice ND 8-month-old Gene deletion; behavioral testing; electrophysiological evaluation of amygdala functions\nAmygdala Psychological outcomes: emotional behavior\n26 [8] Sprague– Dawley rats\n118 ND DPN, behavioral and restraint testing\nNA  Neuroendocrine pathway: HPA reactivity.\n Psychological outcomes (anxiety-like behaviors).\n27 [15] Neonatal Rats (Sprague Dawley) ND ND Xenoestrogens, DPN Immature cerebellar granule cell cultures\nCellular signaling: rapid intracellular signaling\n28 [10] Mice ND ND Gene deletion; WAY200070 or WAY-202779; behavioral tests\nHippocampus Neurological outcomes: hippocampaldependent memory + hippocampal synaptic plasticity\n29 [60] Long-Evans rats\n146 90 days old DPN; behavioral test NA Psychological outcomes: fear generalization\n30 [25] SpragueDawley rats\n69 Adults DPN Hippocampus (Dentate gyrus)\nCellular signaling (cellular proliferation)\n31 [33] SpragueDawley rats\n5 Adults Transfected ER beta 1 Hypothalamus Neuroendocrine pathway\n32 [43] SpragueDawley rats\n8 21 days WAY 200070-2 Hippocampus Neuroprotection\n33 [31] SpragueDawley rats\n10 Adults DPN Prefrontal cortex and hippocampal regions\nCellular signaling(NMDA receptor modulation)\n32\n34 [47] Mice ND 3-4 months Gene deletion, S-DPN NA Psychological and psychiatric (anxietylike behaviors)\n35 [9] SpragueDawley rats\nND 9-11\ndays\nDPN, 17β-Estradiol (E2) Hippocampus  Neuroprotection (against cerebral ischemia)\n Neurological (learning and memory)\n36 [49] Mice 24 ND Gene deletion; 17βEstradiol (E2)\nNA Psychological and psychiatric (antidepressant-like effect)\n37 [7] SpragueDawley rats\nND Adults DPN Hypothalamic paraventricular nucleus\n Cellular signaling  Psychological and psychiatric\n38 [34] Wistar rats 34 10 weeks DPN, EB Hypothalamic ventromedial nucleus\nNeuroendocrine pathway\n39 [30] Wistar rats ND Middle-aged DPN, E2 Frontal cortex Cellular signaling (neuroinflammatory genes regulation) 40 [28] Harlan-Wistar rats 13 13months DPN, E2 Hippocampus Cellular signaling 41 [16] Mice 63 9-20 weeks Gene deletion, estradiol benzoate (EB) Hippocampus (dorsal) Cellular signaling (synaptic plasticity) 42 [26] Mice 120 11 weeks Gene deletion, E2 Subventricular zone Cellular signaling (neurogenesis)\n43 [55] Mice 10 6 months Gene deletion Dorsal raphe nucleus Psychological and psychiatric 44 [53] Long-Evans\nrats 84 55+ days DPN; E2 Hippocampus Psychological and psychiatric\n45 [39] SpragueDawley rats\n9 4-6 months DPN Hippocampus Neurological (ApoE protein expression)\n46 [29] SpragueDawley rats\nND Adults DPN, estradiol benzoate Hippocampus (dorsal region)\nCellular signaling (postsynaptic protein expression)\n47 [58] SpragueDawley rats\n35 Adults DPN Ventromedial prefrontal cortex and amygdala\nPsychological and psychiatric\n33\n48 [40] SpragueDawley rats 3xTg-AD mice\nND 14-16 weeks 12 months DPN; 17β-Estradiol Hippocampus Neurological"
    }, {
      "heading" : "49 [41] OVX",
      "text" : "Triple transgenic AD (3xTg-AD) mice (3 months old) ND 3 months old Phytoestrogenic ER-ß selective modulator (SERM) Formulation, Y-Maze cognition-behavioral test Hippocampus, cortex, cerebellum\nNeurological\nDPN, diarylpropionitrile; EB, estradiol benzoate; E2, 17β-Estradiol; NA, not available; ND, not defined.\n34\nTable 2A. Estrogen Receptor Beta and Cellular Signaling Outcomes No. Reference Outcome Study Sample Brain Tissue Assessment of\nERß function Conclusion Comment\n1 [17] Phospho-cAMP response element binding protein (pCREB) CREB phosphorylation MAPK phosphorylation\nOVX KO/WT Mice\nGnRH neurons in medial septum (MS), rPOA, and anterior hypothalamus\nGene deletion, estradiol (E2)\nNo clear pattern, it depends on brain region\nIt was reported that estradiol induced CREB phosphorylation rapidly through an ER<beta>dependent mechanism.\n2 [12] CREB phosphorylation\nMAPK/ ERK1/2 phosphorylation\nOVX KO/WT Mice\nMedial preoptic nucleus; medial septum; ventrolateral VNM; caudate-putamen; the retrosplenial granulate cortex Gene deletion; 17-ß-estradiol\nNo clear pattern, it depends on brain region\nThe actions of ERß on CREB phosphorylation depends on the brain region: in the medial preoptic septum, phosphorylation of CREB was found to be dependent solely on ERß, whereas no role of this receptor on CREB phosphorylation was found in hypothalamic ventromedial nucleus, caudate-putamen and retrosplenial granulate cortex. ERß plays a role in MAPK phosphorylation in the medial preoptic septum but not in the retrosplenial granulate cortex.\n3 [11] DPN Phosphorylation of both ERK and TrkB OVX SpragueDawley rats Hippocampus DPN Increased SSRI activity, serotonin clearance via activation of ER<beta> slowed.\n35\n4 [13] CREB phosphorylation\nL-type calcium channel-dependent CREB phosphorylation\nL-type calcium channel currents\nIntact rat pups of both sexes\nCA3–CA1 Hippocampal pyramidal neurons culture\nDPN, 17 E-1\nCRCREB phosphorylation: No effect\nL-type calcium channeldependent CREB phosphorylation: reduced (attenuated or decreased)\nL-type calcium channel currents: reduced (attenuated or decreased)\nERβ activates mGlur2 and/or mGlurR3 which leads to diminished cAMP concentrations and a reduction in PKA activity, ultimately resulting in dephosphorylation of Ltype calcium channels and a reduction in L-type calcium channelmediated CREB phosphorylation.\n5 [18] ERK1/2 and CREB phosphorylation in GnRH neurons\nOVX GnRH neuron-specific KO/WT Mice and OVX C57BL/6 Mice GnRH neurons from medial septum (MS) to the anterior hypothalamic area Gene deletion, 17-ß-estradiol\nDirect and indirect positive effect in GnRH neurons\nE2 acts through calcium/calmodulindependent protein kinase type II and protein kinase A to rapidly phosphorylate ERK1/2, which then acts to phosphorylate CREB in adult female GnRH neurons. These effects of E2 are dependent upon both direct ERß mechanisms as well as indirect actions mediated by afferent inputs to GnRH neurons.\n6 [6] Neurogenesis in the dentate gyrus\nKO/WT mice and OVX C57BL/6 mice Dorsal raphe nuclei, dentate gyrus in hippocampus\nSERM-beta1, SERM-beta2, E2, gene deletion, forced swim test (FST) Positive effect\nPositive effect\nERß stimulates neurogenesis in the dentate gyrus.\n7 [14] L-type calcium channel-mediated CREB\nIntact female rat pups\nStriatal neurons culture\nDPN CRCREB phosphorylation: No effect\nERβ activates mGlur2 and therefore leads to a reduction in L-type\n36\nphosphorylation Mglur2 and Mglu3\nL-type calcium channeldependent CREB phosphorylation: reduced (attenuated or decreased)\nERβ activates mGlur3 but not mGlurR2\ncalcium channelmediated CREB phosphorylation.\n8 [27] Mitochondrial DNAencoded COX I expression;\nOVX Sprague– Dawley Rats Isolated brain mitochondria from forebrain\nDPN E2\nPositive effect Activation of ERß is differentially required to potentiate mitochondrial function in brain.\n9 [15] ERK phosphorylation Intact neonatal female Sprague Dawley rats\nImmature cerebellar granule cell cultures\nXenoestrogens; DPN\nPositive effect Rapid intracellular signaling of estrogen is mediated by ER beta.\n10 [10] Protein expression of the AMPAR subunit GluR1 and PSD-95;\nLTP; Dendritic branching and spine number; Spatial memory\nOVX KO/WT Mice\nHippocampus Gene deletion; WAY-200070 or WAY-202779; Behavioral tests\nPositive effect\nPositive effect Positive effect\nPositive effect\nActivation of ERß can regulate hippocampal synaptic plasticity and improve hippocampusdependent cognition.\n11 [25] hippocampal neurogenesis (hippocampal cell proliferation)\nOVX Sprague– Dawley rats n=95\nHippocampus DPN, E2\nIncreased Neurogenesis: (hippocampal cell proliferation)\nERß is involved in estradiol-enhanced cell proliferation.\n12 [31] Modulation of NMDA receptor specific binding OVX Sprague– Dawley rats\nPrefrontal cortex and hippocampus\nDPN, E2\nNo effect Cellular signaling outcomes: (modulation of NMDA receptors)\n37\nn=50\nERß agonist had no effect on hippocampal NMDA receptor-specific binding and NMDAR2B levels. More potent ERß agonist and ⁄ or higher concentrations of DPN may be effective to modulate hippocampal NMDA receptors.\n13 [9] Protection of Hippocampal CA1 Neurons in Oxygen-Glucose Deprivation Model\nIn vitro: brain hippocampal slices from SpragueDawley female rats (9–11 days old) In vivo: OVX Sprague– Dawley rats Hippocampus DPN E2 Behavioral tests\nPositive effect Neuroprotection (against cerebral ischemia).\n14 [7] Desensitization of HT1A receptor signaling.\nOVX, rats Hypothalamic paraventricular nucleus\nDPN No effect DPN did not alter plasma baseline levels of ACTH or oxytocin.\n15 [30] Neuroinflammatory genes regulation\nOVX Wistar rats\nFrontal cortex DPN, E2 Positive effect DPN upregulated the expression of more than sixteen neuroinflammatory genes. ERß may be a target to supress regulatory functions of glial cells in the E2deprived female brain and inflammatory diseases.\n16 [28] mRNA expression in the hippocampus after\nOVX Harlan-Wistar rats\nHippocampus DPN, E2\nERß agonist was capable of attenuating the expression of several\nAfter ovariectomy, E2 and DPN restore the mRNA expression of\n38\ngonadal hormone withdrawal\nn=34 macrophage-associated and complement genes.\ngenes Iba1, Cd68, Cd11b and Cd18. This shows that estrogen replacement partly restores neuronal control of microglia and modulates complement expression.\n17 [16] Gene transcription and protein expression of pAkt-ir, PSD-95-ir and pTrkBir OVX KO/WT Mice n=63 9-20 weeks\nHippocampus Gene deletion, E2\nERß mediates increase in pAkt-ir expression after E2 treatment lasting 6 hrs. Estradiol tended to decrease PSD-95 in BERKO mice: However, this trend was not statistically significant. ERß mediates increase in pTrkB-ir expression after E2 treatment lasting 48 hrs. Cellular signaling outcomes (synaptic plasticity). ERß mediates effects of estradiol on pathways important for synaptic plasticity in the mouse hippocampal formation.\n18 [26] Neurogenesis in animal model of ischemic stroke\nOVX C57BL/6J mice n=90 11 weeks old. Age-matched OVX KO/WT Mice n=30 Subventricular zone (SVZ) of the brain\nGene deletion, E2 Enhanced Neurogenesis: (in an animal model of ischemic stroke).\nERß mediates effects of estradiol treatment on increase in number of newborn neurons in the dorsal SVZ of the adult mouse and on enhancement of neurogenesis in an animal model of ischemic stroke.\n19 [29] Expression of synaptic proteins PSD-95 and AMPA-type glutamate receptor OVX, rats Hippocampus DPN DPN administration increased expression of PSD-95 and AMPA-type glutamate receptor\nCellular signaling outcomes (expression of synaptic proteins in rat hippocampus)\n39\nsubunits GluR1, GluR2 and GluR3.\nsubunit GluR1. DPN administration increased expression of AMPA receptor subunits GluR2 and decreased expression of AMPA receptor subunits GluR3.\nERβ specific agonists regulate the expression of synaptic proteins in rat hippocampus which is important for hippocampal-dependent cognitive performance.\nDPN, diarylpropionitrile; EB, estradiol benzoate; E2, 17β-Estradiol; NA, not available; ND, not defined.\n40\nTable 2B. Estrogen Receptor Beta and Neuroendocrine Pathway Outcomes No. Reference Outcome Study Sample Brain Tissue Assessment of\nERß function Conclusion Comment\n1 [35] T-type calcium channel (subtype Cav3.2) expression and function KO/WT Mice and OVX C57BL/6 mice\nHypothalamic nuclei and pituitary calcium channel subunit: Cav3.1\nGene deletion, Estradiol (E2)\nPositive effect Involvement in excitability of hypothalamic neurons.\n2 [6] Tryptophan hydroxylase-1 (TPH-1) mRNA expression; progesterone receptor expression KO/WT Mice and OVX C57BL/6 Mice\nDorsal raphe nuclei; dentate gyrus in hippocampus\nSERM-beta1, SERM-beta2, E2, gene deletion, forced swim test (FST)\nPositive effect SERM-beta1 and 2 exhibited antidepressant-like effects / ERß may play an important role in modulating mood\n3 [32] Firing of GnRH neurons GABA transmission\nOVX Mice expressing enhanced green fluorescent protein under the control of the GnRH promoter Preoptic area (POA) / hypothalamus\nEstradiol, DPN\nSupporting effect ERß agonist activates GnRH firing, reduces after hyperpolarizing potential (AHP) and increased slow afterdepolarization amplitudes (ADP), and reduced IAHP and enhanced IADP. Also, ERß agonist increased GABA transmission and postsynaptic response in GnRH neuron\n4 [8] CORT and ACTH response to restraint stress\nSprague–Dawley rats of both sexes (OVX females) n=118 NA DPN, behavioral and restraint testing\nDPN reduced CORT and ACTH responses in both males and females. ERβ may modulate HPA (neuroendocrine stress) reactivity.\n5 [33] regulation of the corticotropin-releasing hormone (CRH) promoter\nOVX Sprague–Dawley rats n=5 Hypothalamus Expression vectors: ERß isoforms\nEnhanced (Increased) (positive effect)\nNeuroendocrine pathway: (regulation of the corticotropinreleasing hormone promoter). ERß regulates CRH in\n41\nthe PVH (paraventricular nucleus) of the hypothalamus.\n6 [7] Desensitization of 5- HT1A receptor signaling OVX Sprague–Dawley rats Hypothalamic paraventricular nucleus DPN, recombinant adenoviruscontaining ERß siRNAs\nNo effect Desensitization of 5- HT1A receptor signaling does not appear to be mediated by ERß in oxytocin cells. ERß together with GPR30, may play a complex role in central regulation of 5-HT1A -mediated ACTH release.\n7 [34] estrogen induction of progesterone receptors (PRs)\nOVX Wistar rats (10 weeks of age)\nthe ventrolateral division of the hypothalamic ventromedial nucleus (VMNvl)\nDPN E2\nNo effect Neuroendocrine pathway: (induction of progesterone receptors in hypothalamus).\nSince PR induction by estradiol is required for the display of female sexual behavior obtained data point to the conclusion that activation of the ERß in OVX rats does not facilitate the expression of female sexual behavior.\nDPN, diarylpropionitrile; EB, estradiol benzoate; E2, 17β-Estradiol; NA, not available; ND, not defined.\n42\nTable 2C. Estrogen Receptor Beta and Neurological Outcomes No. Reference Outcome Study Sample Brain Tissue Assessment of ERß\nfunction Conclusion Comment\n1 [36] Hippocampal memory consolidation\np42 ERK phosphorylation\nOVX C57BL/6 mice (8– 12 weeks of age) dorsal hippocampus\nDPN, E2, novel object recognition and object placement behavioral tests\nIncreased\nIncreased\nNeurological outcomes: (hippocampal memory consolidation) ERß/mGluR signaling can mediate the beneficial effects of E2 on hippocampal memory consolidation.\n2 [10] Protein expression of the AMPAR subunit GluR1 and PSD-95;\nLTP; Dendritic branching and spine number; Spatial memory\nOVX KO/WT Mice\nHippocampus Gene deletion; WAY-200070 or WAY-202779; Behavioral tests\nPositive effect\nPositive effect Positive effect\nPositive effect\nActivation of ERß can regulate hippocampal synaptic plasticity and improve hippocampusdependent cognition.\n3 [38] Regulation of gene transcription and learning in the hippocampus\nOVX KO/WT Mice n=163\nHippocampus Gene deletion, estradiol (17 ßestradiol benzoate); behavioral studies\nPositive effect ERß interacts with estradiol levels to regulate transcription involved in maintaining hippocampal function (hippocampal dependent\n43\nmemory) during aging\n4 [37] Recognition memory\nBrain monoamines levels\nOVX Sprague Dawley rats n=32-34\nNA DPN, estradiol benzoate; behavioral tests (object recognition / placement memory tasks)\nPositive effect\nIncreased\nERß mediates sub chronic and acute effects of estrogens on recognition memory. Memory enhancements may occur, in part, through alterations in monoaminergiccontaining systems primarily in PFC and hippocampus.\n5 [9] Post-ischemic Learning and Memory\nIn vitro: brain hippocampal slices from SpragueDawley female rats (9–11 days old) In vivo: OVX Sprague–Dawley rats Hippocampus DPN, E2, behavioral tests\nImproved by periodic activation of ERß\nNeurological outcome: (learning and memory). ERß intracellular signaling mediates improvement of post-ischemic outcome and cognition induced by long-term periodic E2 treatment in the hippocampus of OvX female rats.\n6 [39] Apolipoprotein E expression in hippocampus in vitro and in vivo Rat Hippocampal Neurons in Primary Culture /\nOVX Sprague–Dawley rats\nHippocampus DPN Decreased / ERβ selective agonist, DPN, down-regulated ApoE mRNA and protein expression. Neurological outcome: AD\nUse of ER-selective ligands could provide therapeutic benefit to reduce the risk of AD by increasing ApoE\n44\nn=9 (4-6 months old)\nexpression in ApoE2/3 allele carriers and decreasing ApoE expression in ApoE4 allele carriers.\n7 [40] Insulin-degrading enzyme(IDE) mRNA and protein expression OVX Sprague–Dawley rats(14 to 16-week-old)\nA triple transgenic AD(3xTg-AD) mice\nHippocampus, cortex and cerebellum\nDPN, E2\nTreatment with DPN increased IDE protein expression in rat hippocampal neurons\nNeurological outcome: AD prevention; ERß/PI3-K pathway modulates effects of 17ß-E2 on regulation of insulin-degrading enzyme (IDE) expression in a brain regionspecific manner. Such regulatory role in the hippocampus could serve as a direct mechanism underlying estrogen-mediated preventative effect against AD when initiated at the onset of menopause.\n8 [41] Regulation of early stages of physical and neurological changes associated with AD\nOVX Triple transgenic AD (3xTg-AD) mice (3 months old)\nHippocampus, cortex, cerebellum\nPhytoestrogenic ERß selective modulator (SERM) formulation containing equal parts of genistein, daidzein, and equol. Y-Maze cognitionbehavioral test When initiated prior to the appearance of AD pathology, a 9-month dietary supplementation with the phyto- ß -SERM formulation promoted physical health, prolonged survival, improved spatial recognition memory, and attenuated amyloid-ß\nNeurological outcome: AD Obtained results support the therapeutic potential of the phyto- ß – SERM formulation for prevention and/or early\n45\ndeposition and plaque formation in the brains of treated AD mice.\nintervention of AD, and warrant further investigations in human studies.\nDPN, diarylpropionitrile; EB, estradiol benzoate; E2, 17β-Estradiol; NA, not available; ND, not defined.\n46\nTable 2D. Estrogen Receptor Beta and Neuroprotection Outcomes\nNo. Reference Outcome Study Sample Brain Tissue Assessment of ERß function\nConclusion Comment\n1 [44] Regulation of brain cytokine and chemokine levels;\nRegulation of BBB permeability\nOVX KO/WT Mice\nCortex and striatum\nGene deletion; E2; Cytokine/chemokine quantification.\nPositive effect\nPositive effect\nERß regulates proinflammatory cytokine and chemokine production through E2dependent and E2independent mechanisms. ERß is essential for E2-mediated regulation of BBB permeability.\n2 [42] Induction of transient global ischemia by bilateral carotid artery occlusion\nOVX C57BL/6J mice n=44\nCaudate nucleus and dorsal hippocampus\nDPN DPN significantly reduced ischemic damage by 70% in the caudate nucleus and 55% in the CA1 region compared with vehicle controls. ERß activation is neuroprotective in global cerebral ischemia mouse model.\n3 [43] Protection of hippocampal neurons in a global ischemia model\nOVX Sprague–Dawley rats (21 days old)\nHippocampus WAY 200070-3 ERß-selective agonist WAY 200070–3 produced nearly complete protection of CA1 neurons in approximately 50% of the animals.\nNeuroprotection: (protection of hippocampal neurons in global ischemia model) ERß mediates estradiol protection of CA1 hippocampal neurons from global ischemia-induced\n47\ncell death. 4 [9] Protection of\nHippocampal CA1 Neurons in Oxygen-Glucose Deprivation Model In vitro: brain hippocampal slices from Sprague-Dawley female rats (9–11 days old) In vivo: OVX Sprague–Dawley rats\nHippocampus DPN E2 Behavioral tests\nPositive effect Neuroprotection (against cerebral ischemia).\nDPN, diarylpropionitrile; EB, estradiol benzoate; E2, 17β-Estradiol; NA, not available; ND, not defined.\n48\nTable 2E. Estrogen Receptor Beta and Psychological/Psychiatric Outcomes No. Reference Outcome Study Sample Brain Tissue Assessment of ERß\nfunction Conclusion Comment\n1 [51] Depression-like behavior\nMemory impairment\nOVX Sprague– Dawley rats\nNA DPN DPN markedly prevented memory impairment and decreased immobility time in OVX or diabetic rats\nDPN decreased immobility time in the forced swim test when compared to controls. Memory improvement was suggested by DPN decreasing the total distance traveled in a water maze.\n2 [52] Depression-like behavior\nNon-spatial memory\nOVX C57BL/6 mice Hippocampus DPN, E2 DPN decreased the immobility time; the depressive-like behavior of mice in the forced swim test.\nDPN rescued object recognition memory by acting on early stages of memory consolidation. These effects were observed up to 12 weeks after ovariectomy; demonstrating that 12 weeks of OVX is not a sufficient time to abolish the beneficial effects of E2.\n3 [48] Assessment of serotonin clearance\nOVX Sprague– Dawley rats\nCA3 region of the hippocampus\nDPN, E2\nThe E2-induced slowing of serotonin clearance via activation of ERβ required MAPK/ERK1/2 signaling pathways and involved interactions both with TrkB and IGF-1R. Activation of ERβ induced by E2 slows serotonin clearance / Antidepressantlike effect of estradiol is mediated by ERβ.\n4 [11] Depression-like OVX Sprague- NA DPN DPN at 5 or 10 Increasing the\n49\nbehavior Dawley rats micrograms induced antidepressant-like effects during the forced swim test.\ndosage from 5 micrograms to 10 of DPN was not found to produce antidepressantlike effects.\n5 [56] Social recognition\nSocial anxiety\nKO/WT Mice and OVX Swiss Webster mice n=89 NA Gene deletion, social recognition paradigm (tests) and behavioral analysis.\nß-ERKO mice were selectively impaired in social recognition but not in overall activity. The reduced social anxiety was found in the ß-ERKO mice.\nGenes for ERß play a crucial role in oxytocindependent social recognition. Estrogen modulation of female psychosocial anxiety depends on ER-ß.\n6 [57] Social recognition (binary social discrimination assay)\nKO/WT Mice and OVX Swiss Webster mice n=88 NA Gene deletion, social recognition paradigm (tests) and behavioral analysis. ß-ERKO mice showed partially impaired social discrimination.\nERß genes are necessary for social discrimination and, thus, for the modulation of social behavior (e.g., aggression, affiliation).\n7 [6] Tryptophan hydroxylase-1 (TPH1) mRNA expression; progesterone receptor expression KO/WT Mice and OVX C57BL/6 Mice Dorsal raphe nuclei; dentate gyrus in hippocampus SERM-beta1, SERM-beta2, E2, gene deletion, forced swim test (FST)\nPositive effect SERM-beta1 and 2 exhibited antidepressantlike effects / ERß may play an important role in modulating mood\n50\n8 [50] TryptophanHydroxylase 2 mRNA expression\nAnxiety-like behaviors\nDespair-like behavior\nOVX Sprague– Dawley rats\nBrainstem (dorsal raphe nuclei)\nSystemic and local application of DPN, Behavioral testing\nPositive effect\nSystemic delivery of DPN decreased anxiety-like behavior, while local administration of DPN failed to have the same effect. Local DPN administration in animals showed decreased despair-like behavior. does not alter anxiety-like behaviors, but enhances active stresscoping behavior.\nERß acts at the level of the rat DRN to modulate tph2 mRNA expression and thereby influence serotoninsynthesis in DRN subregions.\nLocal activation of ERß neurons in the DRN may be sufficient to decrease despairlike behavior, but not anxiolytic behaviors.\n9 [59] Fear extinction C57/BL6 mice Infralimbic medial prefrontal cortex DPN Increased ERß activation facilitates the infralimbic medial prefrontal cortex to undergo potentiation; necessary for the regulation of fear extinction. 10 [54] TPH1 mRNA expression\nKO/WT mice and OVX C57BL/6 mice\nDorsal raphe nucleus (DRN) in midbrain\nGene deletion, estradiol\nPositive effect ERß might be responsible for mediating estrogen regulated TPH1 expression in the murine DRN. / ERß might be a key mediator of estrogen\n51\naction in serotonergic neurons.\n11 [45] Anxiety-like behavior\nMeasurement of brain serotonin and dopamine levels\nOVX KO/WT mice n=80\nCingulate cortex; caudate putamen; nucleus accumbens; medial septum; stria terminalis; hippocampus; posterodorsal amygdale; substantia nigra; dorsal raphe, locus coeruleus Gene deletion, E2, behavioral testing (the elevated plusmaze test), monoamine HPLC\nIn the absence of functional ERß female mice exhibited enhanced anxiety and decreased concentrations of serotoninor dopamine in several brain regions.\nERß may modulate estrogen effects on anxiety and catecholamine concentrations.\n12 [46] Anxiety-like behavior\n5-HT1a receptor expression in amygdala\nSynaptic plasticity in the amygdala\nKO/WT mice both sexes\nAmygdala Gene deletion, behavioral testing; electrophysiological evaluation of amygdala functions.\nERß mutant females showed increased anxiety.\nPositive effect\nEnhanced anxiety is associated with a reduced threshold for synaptic plasticity in the amygdala, principally in female mice.\nERß mediates estrogen signaling in the processing of emotional behavior particularly in females. / ERß may be critically involved in the expression of anxiety disorders to which females may be particularly susceptible.\n13 [8] Anxiety and depressive-like behavior\nSprague– Dawley rats of both sexes NA DPN, behavioral and restraint testing\nDPN effectively increased anxiolytic behaviors\nERβ may reduce anxiety-like behavior.\n52\n(OVX females) n=118\nmore effectively in females. Females responded to DPN with an antidepressive like response whereas males did not respond to treatment.\n14 [60] Fear generalization Long-Evans rats\nNA DPN, behavioral test. Increased DPN at a 2.5 mg dose increased fear generalization through an effect on fear memory retrieval mechanisms by activation of ERß.\n15 [47] Anxiety-like behaviors\nOVX KO/WT Mice 3-4 months of age\nAnterodorsal medial amygdala and bed nucleus of the stria terminalis\nGene deletion, S-DPN, E2, behavioral tests\nReduced by DPN administration\nPsychological outcomes: (mediation of anxiety-like behaviors). ERß mediates anxiolytic actions of estradiol.\n16 [49] Depression-like behavior through total duration of immobility in the Forced Swim Test (FST)\nOVX: CD1 Mice (n=171) 129S6 Mice (n=35) KO/WT Mice (n=24)\nNA Gene deletion, E2, behavioral tests\nE2 did not reduce immobility in the FST in BERKO mice\nPsychological outcomes: (antidepressantlike effects). ER-β receptors are implicated in the antidepressantlike effects of E2 in mice.\n17 [55] Expression of tryptophan hydroxylase (TPH) in OVX KO/WT Mice n=45\nDorsal raphe nucleus\nGene deletion, LY3201 (selective ERß agonist),\n3-day treatment with LY3201 L has a rapid onset effect Psychological outcomes: (serotonergic\n53\nthe Dorsal raphe (DR),\nAlterations in glucose homeostasis.\n6 months old E2 on serotonergic activity with increased expression of TPH and ERß.\nLY3201 only restored TPH expression in the DR when the duration of estrogen deprivation was less than 10 weeks. 3-day treatment with LY3201 causes only mild alterations in glucose homeostasis but effectively restored TPH expression in the DR.\nactivity). ERß agonists could be useful pharmaceuticals in maintaining functional DR neurons to treat postmenopausal depression.\n18 [53] Anxiety and depressive behavior\nOVX Long–Evans rats (n=84) (55+ d old)\nHippocampus Estrogen receptor beta-specific selective estrogen Receptor modulators (DPN), behavioral testing\nERβ-selective SERMs to the hippocampus, but not the ventral tegmental area, decreased anxiety and depressive behavior.\nPsychological outcomes: (Anxiety and depressive behavior) Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats.\n19 [58] Extinction memory Sprague– Ventromedial DPN and behavioral Administration of the Psychological\n54\nexpression during extinction recall (learning not to fear). Dawley naturally cycling rats n=81\nprefrontal cortex (vmPFC) and amygdala tests (extinction recall learning trials) in animals estrogen-receptor beta agonist facilitated extinction recall.\noutcomes: (fear extinction recall) ERß modulates effects of estradiol on facilitation of extinction memory consolidation in a time-dependent manner in rodents.\nDPN, diarylpropionitrile; EB,"
    } ],
    "references" : [ {
      "title" : "Neurologic diseases in women",
      "author" : [ "M.A. O'Neal" ],
      "venue" : "Neurology Clinical Practice",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2013
    }, {
      "title" : "ERbeta: recent understanding of estrogen signaling",
      "author" : [ "N. Sugiyama", "R.P. Barros", "M. Warner", "J.A. Gustafsson" ],
      "venue" : "Trends Endocrinol Metab 21(9) ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Estrogen receptor beta actions in the female cardiovascular system: A systematic review of animal and human studies",
      "author" : [ "T. Muka", "K.G. Vargas", "L. Jaspers", "K.X. Wen", "K. Dhana", "A. Vitezova", "J. Nano", "A. Brahimaj", "V. Colpani", "A. Bano", "B. Kraja", "A. Zaciragic", "W.M. Bramer", "G.M. Dijk", "M. Kavousi", "O.H. Franco" ],
      "venue" : "Maturitas 86 ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Selective estrogen receptor-beta (SERMbeta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test",
      "author" : [ "J.A. Clark", "S. Alves", "C. Gundlah", "B. Rocha", "E.T. Birzin", "S.J. Cai", "R. Flick", "E. Hayes", "K. Ho", "S. Warrier", "L. Pai", "J. Yudkovitz", "R. Fleischer", "L. Colwell", "S. Li", "H. Wilkinson", "J. Schaeffer", "R. Wilkening", "E. Mattingly", "M. Hammond", "S.P. Rohrer" ],
      "venue" : "Neuropharmacology 63(6) ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta",
      "author" : [ "D.V. Rossi", "Y. Dai", "P. Thomas", "G.A. Carrasco", "L.L. DonCarlos", "N.A. Muma", "Q. Li" ],
      "venue" : "Psychoneuroendocrinology 35(7) ",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Estrogen receptor beta and oxytocin interact to modulate anxiety-like behavior and neuroendocrine stress reactivity in adult male and female rats",
      "author" : [ "A.E. Kudwa", "R.F. McGivern", "R.J. Handa" ],
      "venue" : "Physiol Behav 129 ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Periodic 17beta-estradiol pretreatment protects rat brain from cerebral ischemic damage via estrogen receptor-beta",
      "author" : [ "A.P. Raval", "R. Borges-Garcia", "W. Javier Moreno", "M.A. Perez-Pinzon", "H. Bramlett" ],
      "venue" : "PLoS One 8(4) ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory",
      "author" : [ "F. Liu", "M. Day", "L.C. Muniz", "D. Bitran", "R. Arias", "R. Revilla-Sanchez", "S. Grauer", "G. Zhang", "C. Kelley", "V. Pulito", "A. Sung", "R.F. Mervis", "R. Navarra", "W.D. Hirst", "P.H. Reinhart", "K.L. Marquis", "S.J. Moss", "M.N. Pangalos", "N.J. Brandon" ],
      "venue" : "Nat Neurosci 11(3) ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats",
      "author" : [ "S. Benmansour", "O.S. Adeniji", "A.A. Privratsky", "A. Frazer" ],
      "venue" : "Neuroendocrinology ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain",
      "author" : [ "I.M. Abraham", "M.G. Todman", "K.S. Korach", "A.E. Herbison" ],
      "venue" : "Endocrinology 145(7) ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Estradiol activates group I and II metabotropic glutamate receptor signaling",
      "author" : [ "M.I. Boulware", "J.P. Weick", "B.R. Becklund", "S.P. Kuo", "R.D. Groth", "P.G. Mermelstein" ],
      "venue" : "leading to opposing influences on cAMP response element-binding protein, J Neurosci 25(20) ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons",
      "author" : [ "D. Grove-Strawser", "M.I. Boulware", "P.G. Mermelstein" ],
      "venue" : "Neuroscience 170(4) ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Rapid signaling actions of environmental estrogens in developing granule cell neurons are mediated by estrogen receptor ss",
      "author" : [ "H.H. Le", "S.M. Belcher" ],
      "venue" : "Endocrinology 151(12) ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation",
      "author" : [ "J.L. Spencer-Segal", "M.C. Tsuda", "L. Mattei", "E.M. Waters", "R.D. Romeo", "T.A. Milner", "B.S. McEwen", "S. Ogawa" ],
      "venue" : "Neuroscience 202 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Estrogen receptor beta mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo",
      "author" : [ "I.M. Abraham", "S.K. Han", "M.G. Todman", "K.S. Korach", "A.E. Herbison" ],
      "venue" : "J Neurosci 23(13) ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Estradiol acts directly and indirectly on multiple signaling pathways to phosphorylate cAMPresponse element binding protein in GnRH neurons",
      "author" : [ "R.Y. Cheong", "A. Kwakowsky", "Z. Barad", "R. Porteous", "A.E. Herbison", "I.M. Abraham" ],
      "venue" : "Endocrinology 153(8) ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Pathological roles of MAPK signaling pathways in human diseases",
      "author" : [ "E.K. Kim", "E.J. Choi" ],
      "venue" : "Biochim Biophys Acta 1802(4) ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Deficient longterm memory in mice with a targeted mutation of the cAMP-responsive element-binding protein",
      "author" : [ "R. Bourtchuladze", "B. Frenguelli", "J. Blendy", "D. Cioffi", "G. Schutz", "A.J. Silva" ],
      "venue" : "Cell 79(1) ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 1994
    }, {
      "title" : "Sex differences in basal and cocaine-induced alterations in PKA and CREB proteins in the nucleus accumbens",
      "author" : [ "A. Nazarian", "W.L. Sun", "L. Zhou", "L.M. Kemen", "S. Jenab", "V. Quinones-Jenab" ],
      "venue" : "Psychopharmacology (Berl) 203(3) ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "CREB regulation of BK channel gene expression underlies rapid drug tolerance",
      "author" : [ "Y. Wang", "A. Ghezzi", "J.C. Yin", "N.S. Atkinson" ],
      "venue" : "Genes Brain Behav 8(4) ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "A role for calmodulinstimulated adenylyl cyclases in cocaine sensitization",
      "author" : [ "D.P. DiRocco", "Z.S. Scheiner", "C.B. Sindreu", "G.C. Chan", "D.R. Storm" ],
      "venue" : "J Neurosci 29(8) ",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders",
      "author" : [ "C. Rouaux", "J.P. Loeffler", "A.L. Boutillier" ],
      "venue" : "Biochem Pharmacol 68(6) ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Both estrogen receptor alpha and estrogen receptor beta agonists enhance cell proliferation in the dentate gyrus of adult female rats",
      "author" : [ "C.A. Mazzucco", "S.E. Lieblich", "B.I. Bingham", "M.A. Williamson", "V. Viau", "L.A.M. Galea" ],
      "venue" : "Neuroscience 141(4) ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta",
      "author" : [ "S. Suzuki", "L.M. Gerhold", "M. Bottner", "S.W. Rau", "C. Dela Cruz", "E. Yang", "H. Zhu", "J. Yu", "A.B. Cashion", "M.S. Kindy", "I. Merchenthaler", "F.H. Gage", "P.M. Wise" ],
      "venue" : "J Comp Neurol 500(6) ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function",
      "author" : [ "R.W. Irwin", "J. Yao", "J. To", "R.T. Hamilton", "E. Cadenas", "R.D. Brinton" ],
      "venue" : "J Neuroendocrinol 24(1) ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Ovariectomy and subsequent treatment with estrogen receptor agonists tune the innate immune system of the hippocampus in middle-aged female rats",
      "author" : [ "M. Sarvari", "I. Kallo", "E. Hrabovszky", "N. Solymosi", "Z. Liposits" ],
      "venue" : "PLoS One 9(2) ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Estrogen receptor alpha and beta specific agonists regulate expression of synaptic proteins in rat hippocampus",
      "author" : [ "E.M. Waters", "K. Mitterling", "J.L. Spencer", "S. Mazid", "B.S. McEwen", "T.A. Milner" ],
      "venue" : "Brain Res 1290 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Estrogens regulate neuroinflammatory genes via estrogen receptors alpha and beta in the frontal cortex of middle-aged female rats",
      "author" : [ "M. Sarvari", "E. Hrabovszky", "I. Kallo", "N. Solymosi", "K. Toth", "I. Liko", "J. Szeles", "S. Maho", "B. Molnar", "Z. Liposits" ],
      "venue" : "J Neuroinflammation 8 ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors",
      "author" : [ "M. Morissette", "M. Le Saux", "T. Di Paolo" ],
      "venue" : "J Neuroendocrinol 20(8) ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Differential regulation of gonadotropinreleasing hormone neuron activity and membrane properties by acutely applied estradiol: dependence on dose and estrogen receptor subtype",
      "author" : [ "Z. Chu", "J. Andrade", "M.A. Shupnik", "S.M. Moenter" ],
      "venue" : "J Neurosci 29(17) ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway",
      "author" : [ "W.J. Miller", "S. Suzuki", "L.K. Miller", "R. Handa", "R.M. Uht" ],
      "venue" : "J Neurosci 24(47) ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Role of estrogen receptor alpha and beta in the induction of progesterone receptors in hypothalamic ventromedial neurons",
      "author" : [ "S.I. Sa", "P.A. Pereira", "V. Malikov", "M.D. Madeira" ],
      "venue" : "Neuroscience 238 ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta",
      "author" : [ "M.A. Bosch", "J. Hou", "Y. Fang", "M.J. Kelly", "O.K. Ronnekleiv" ],
      "venue" : "J Comp Neurol 512(3) ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling",
      "author" : [ "M.I. Boulware", "J.D. Heisler", "K.M. Frick" ],
      "venue" : "J Neurosci 33(38) ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Estradiol and ERbeta agonists enhance recognition memory",
      "author" : [ "L.F. Jacome", "C. Gautreaux", "T. Inagaki", "G. Mohan", "S. Alves", "L.S. Lubbers", "V. Luine" ],
      "venue" : "and DPN, an ERbeta agonist, alters brain monoamines, Neurobiol Learn Mem 94(4) ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Role of estrogen receptor alpha and beta in preserving hippocampal function during aging",
      "author" : [ "X. Han", "K.K. Aenlle", "L.A. Bean", "A. Rani", "S.L. Semple-Rowland", "A. Kumar", "T.C. Foster" ],
      "venue" : "J Neurosci 33(6) ",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo",
      "author" : [ "J.M. Wang", "R.W. Irwin", "R.D. Brinton" ],
      "venue" : "Proc Natl Acad Sci U S A 103(45) ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention",
      "author" : [ "L. Zhao", "J. Yao", "Z. Mao", "S. Chen", "Y. Wang", "R.D. Brinton" ],
      "venue" : "Neurobiol Aging 32(11) ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Early intervention with an estrogen receptor beta-selective phytoestrogenic formulation prolongs survival",
      "author" : [ "L. Zhao", "Z. Mao", "S. Chen", "L.S. Schneider", "R.D. Brinton" ],
      "venue" : "improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease, J Alzheimers Dis 37(2) ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia",
      "author" : [ "H.V. Carswell", "I.M. Macrae", "L. Gallagher", "E. Harrop", "K.J. Horsburgh" ],
      "venue" : "Am J Physiol Heart Circ Physiol 287(4) ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death",
      "author" : [ "N.R. Miller", "T. Jover", "H.W. Cohen", "R.S. Zukin", "A.M. Etgen" ],
      "venue" : "Endocrinology 146(7) ",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta",
      "author" : [ "C.M. Brown", "T.A. Mulcahey", "N.C. Filipek", "P.M. Wise" ],
      "venue" : "Endocrinology 151(10) ",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice",
      "author" : [ "D.B. Imwalle", "J.A. Gustafsson", "E.F. Rissman" ],
      "venue" : "Physiol Behav 84(1) ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice",
      "author" : [ "W. Krezel", "S. Dupont", "A. Krust", "P. Chambon", "P.F. Chapman" ],
      "venue" : "Proc Natl Acad Sci U S A 98(21) ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "Anxiolytic effects and neuroanatomical targets of estrogen receptor-beta (ERbeta) activation by a selective ERbeta agonist in female mice",
      "author" : [ "M.G. Oyola", "W. Portillo", "A. Reyna", "C.D. Foradori", "A. Kudwa", "L. Hinds", "R.J. Handa", "S.K. Mani" ],
      "venue" : "Endocrinology 153(2) ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance",
      "author" : [ "S. Benmansour", "A.A. Privratsky", "O.S. Adeniji", "A. Frazer" ],
      "venue" : "Int J Neuropsychopharmacol 17(5) ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "17 Beta-estradiolinduced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice",
      "author" : [ "B.A. Rocha", "R. Fleischer", "J.M. Schaeffer", "S.P. Rohrer", "G.J. Hickey" ],
      "venue" : "Psychopharmacology (Berl) 179(3) ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Estrogen receptor beta regulates the expression of tryptophanhydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei",
      "author" : [ "N. Donner", "R.J. Handa" ],
      "venue" : "Neuroscience 163(2) ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Differential role of estrogen receptor modulators in depression-like behavior and memory impairment in rats with postmenopausal diabetes",
      "author" : [ "S. Bansal", "K. Chopra" ],
      "venue" : "Menopause 22(10) ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Object recognition memory deficit and depressive-like behavior caused by chronic ovariectomy can be transitorialy recovered by the acute activation of hippocampal estrogen receptors",
      "author" : [ "C.P. Bastos", "L.M. Pereira", "T.H. Ferreira-Vieira", "L.E. Drumond", "A.R. Massensini", "M.F. Moraes", "G.S. Pereira" ],
      "venue" : "Psychoneuroendocrinology 57 ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats",
      "author" : [ "A.A. Walf", "C.A. Frye" ],
      "venue" : "Pharmacol Biochem Behav 86(2) ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe",
      "author" : [ "C. Gundlah", "S.E. Alves", "J.A. Clark", "L.Y. Pai", "J.M. Schaeffer", "S.P. Rohrer" ],
      "venue" : "Biol Psychiatry 57(8) ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Involvement of estrogen receptor beta in maintenance of serotonergic neurons of the dorsal raphe",
      "author" : [ "H. Suzuki", "R.P. Barros", "N. Sugiyama", "V. Krishnan", "B.C. Yaden", "H.J. Kim", "M. Warner", "J.A. Gustafsson" ],
      "venue" : "Mol Psychiatry 18(6) ",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "An estrogendependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice",
      "author" : [ "E. Choleris", "J.A. Gustafsson", "K.S. Korach", "L.J. Muglia", "D.W. Pfaff", "S. Ogawa" ],
      "venue" : "Proc Natl Acad Sci U S A 100(10) ",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Involvement of estrogen receptor alpha",
      "author" : [ "E. Choleris", "S. Ogawa", "M. Kavaliers", "J.A. Gustafsson", "K.S. Korach", "L.J. Muglia", "D.W. Pfaff" ],
      "venue" : "beta and oxytocin in social discrimination: A detailed behavioral analysis with knockout female mice, Genes Brain Behav 5(7) ",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats",
      "author" : [ "M.A. Zeidan", "S.A. Igoe", "C. Linnman", "A. Vitalo", "J.B. Levine", "A. Klibanski", "J.M. Goldstein", "M.R. Milad" ],
      "venue" : "Biol Psychiatry 70(10) ",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Regulation of the mouse medial prefrontal cortical synapses by endogenous estradiol",
      "author" : [ "C. Galvin", "I. Ninan" ],
      "venue" : "Neuropsychopharmacology 39(9) ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "3rd",
      "author" : [ "J.F. Lynch" ],
      "venue" : "D. Dejanovic, P. Winiecki, J. Mulvany, S. Ortiz, D.C. Riccio, A.M. Jasnow, Activation of ERbeta modulates fear generalization through an effect on memory retrieval, Horm Behav 66(2) ",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Girdin phosphorylation is crucial for synaptic plasticity and memory: a potential role in the interaction of BDNF/TrkB/Akt signaling with NMDA receptor",
      "author" : [ "T. Nakai", "T. Nagai", "M. Tanaka", "N. Itoh", "N. Asai", "A. Enomoto", "M. Asai", "S. Yamada", "A.B. Saifullah", "M. Sokabe", "M. Takahashi", "K. Yamada" ],
      "venue" : "J Neurosci 34(45) ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease",
      "author" : [ "Y.S. Choi", "B. Lee", "H.Y. Cho", "I.B. Reyes", "X.A. Pu", "T.C. Saido", "K.R. Hoyt", "K. Obrietan" ],
      "venue" : "Neurobiol Dis 36(2) ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Major depressive disorder",
      "author" : [ "R.H. Belmaker", "G. Agam" ],
      "venue" : "N Engl J Med 358(1) ",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "The nuclear transcription factor CREB: involvement in addiction",
      "author" : [ "C.S. McPherson", "A.J. Lawrence" ],
      "venue" : "deletion models and looking forward, Curr Neuropharmacol 5(3) ",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Metabotropic glutamate receptors: physiology",
      "author" : [ "C.M. Niswender", "P.J. Conn" ],
      "venue" : "pharmacology, and disease, Annu Rev Pharmacol Toxicol 50 ",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Metabotropic glutamatergic receptors and their ligands in drug addiction",
      "author" : [ "L. Pomierny-Chamiolo", "K. Rup", "B. Pomierny", "E. Niedzielska", "P.W. Kalivas", "M. Filip" ],
      "venue" : "Pharmacol Ther 142(3) ",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "A Critical Kinase Cascade in Neurological Disorders: PI 3-K",
      "author" : [ "Z.Z. Chong", "Y.C. Shang", "S. Wang", "K. Maiese" ],
      "venue" : "Akt, and mTOR, Future Neurol 7(6) ",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "L",
      "author" : [ "F. Boulle", "G. Kenis", "M. Cazorla", "M. Hamon", "H.W. Steinbusch" ],
      "venue" : "Lanfumey, D.L. van den Hove, TrkB inhibition as a therapeutic target for CNS-related disorders, Prog Neurobiol 98(2) ",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Immunolocalization of estrogen  24  receptor beta in the mouse brain: comparison with estrogen receptor alpha",
      "author" : [ "S.W. Mitra", "E. Hoskin", "J. Yudkovitz", "L. Pear", "H.A. Wilkinson", "S. Hayashi", "D.W. Pfaff", "S. Ogawa", "S.P. Rohrer", "J.M. Schaeffer", "B.S. McEwen", "S.E. Alves" ],
      "venue" : "Endocrinology 144(5) ",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner",
      "author" : [ "P. Tanapat", "N.B. Hastings", "E. Gould" ],
      "venue" : "J Comp Neurol 481(3) ",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Estradiol initially enhances but subsequently suppresses (via adrenal steroids) granule cell proliferation in the dentate gyrus of adult female rats",
      "author" : [ "B.K. Ormerod", "T.T. Lee", "L.A. Galea" ],
      "venue" : "J Neurobiol 55(2) ",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus",
      "author" : [ "J.E. Malberg", "A.J. Eisch", "E.J. Nestler", "R.S. Duman" ],
      "venue" : "J Neurosci 20(24) ",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "Estrogen receptor beta in the brain: from form to function",
      "author" : [ "M.J. Weiser", "C.D. Foradori", "R.J. Handa" ],
      "venue" : "Brain Res Rev 57(2) ",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Maternal behavior in transgenic mice with reduced fibroblast growth factor receptor function in gonadotropin-releasing hormone neurons",
      "author" : [ "L.R. Brooks", "C.D. Le", "W.C. Chung", "P.S. Tsai" ],
      "venue" : "Behav Brain Funct 8 ",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women",
      "author" : [ "M. Pirskanen", "M. Hiltunen", "A. Mannermaa", "S. Helisalmi", "M. Lehtovirta", "T. Hanninen", "H. Soininen" ],
      "venue" : "Eur J Hum Genet 13(9) ",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan",
      "author" : [ "M. Abu-Taha", "C. Rius", "C. Hermenegildo", "I. Noguera", "J.M. Cerda-Nicolas", "A.C. Issekutz", "P.J. Jose", "J. Cortijo", "E.J. Morcillo", "M.J. Sanz" ],
      "venue" : "J Immunol 183(2) ",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Estrogen-mediated effects on cognition and synaptic plasticity: what do estrogen receptor knockout models tell us",
      "author" : [ "H.J. Kim", "G. Casadesus" ],
      "venue" : "Biochim Biophys Acta 1800(10) ",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2010
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "predisposing women to Alzheimer’s disease (AD) and stroke [3].",
      "startOffset" : 58,
      "endOffset" : 61
    }, {
      "referenceID" : 0,
      "context" : "hypoestrogenic state through hormonal replacement therapy seems to be insufficient.[3] Estrogen,",
      "startOffset" : 83,
      "endOffset" : 86
    }, {
      "referenceID" : 1,
      "context" : "be widely distributed throughout the brain [4, 5].",
      "startOffset" : 43,
      "endOffset" : 49
    }, {
      "referenceID" : 2,
      "context" : "be widely distributed throughout the brain [4, 5].",
      "startOffset" : 43,
      "endOffset" : 49
    }, {
      "referenceID" : 1,
      "context" : "used as targets for novel therapeutic agents against common neurological and behavioral disorders [4].",
      "startOffset" : 98,
      "endOffset" : 101
    }, {
      "referenceID" : 6,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 8,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 9,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 10,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 11,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 12,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 13,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 14,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 15,
      "context" : "assessed the effect of phosphorylation in different subunits [9, 11-18].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 8,
      "context" : "[11, 12, 15, 16] reported that activation of ERβ was associated with increased immunoreactivity and",
      "startOffset" : 0,
      "endOffset" : 16
    }, {
      "referenceID" : 9,
      "context" : "[11, 12, 15, 16] reported that activation of ERβ was associated with increased immunoreactivity and",
      "startOffset" : 0,
      "endOffset" : 16
    }, {
      "referenceID" : 12,
      "context" : "[11, 12, 15, 16] reported that activation of ERβ was associated with increased immunoreactivity and",
      "startOffset" : 0,
      "endOffset" : 16
    }, {
      "referenceID" : 13,
      "context" : "[11, 12, 15, 16] reported that activation of ERβ was associated with increased immunoreactivity and",
      "startOffset" : 0,
      "endOffset" : 16
    }, {
      "referenceID" : 15,
      "context" : "Also, one study [18] found that ERβ was involved",
      "startOffset" : 16,
      "endOffset" : 20
    }, {
      "referenceID" : 16,
      "context" : "Parkinson’s Disease, and amyotrophic lateral sclerosis [19].",
      "startOffset" : 55,
      "endOffset" : 59
    }, {
      "referenceID" : 14,
      "context" : "Furthermore, two studies [17, 18] reported an involvement of",
      "startOffset" : 25,
      "endOffset" : 33
    }, {
      "referenceID" : 15,
      "context" : "Furthermore, two studies [17, 18] reported an involvement of",
      "startOffset" : 25,
      "endOffset" : 33
    }, {
      "referenceID" : 9,
      "context" : "ERβ in CREB phosphorylation in GnRH neurons whereas another study [12] found regional actions of",
      "startOffset" : 66,
      "endOffset" : 70
    }, {
      "referenceID" : 6,
      "context" : "increased protein expression of phosphorylated CREB [9].",
      "startOffset" : 52,
      "endOffset" : 55
    }, {
      "referenceID" : 17,
      "context" : "physiological dependence and Huntington’s Disease [20-24].",
      "startOffset" : 50,
      "endOffset" : 57
    }, {
      "referenceID" : 18,
      "context" : "physiological dependence and Huntington’s Disease [20-24].",
      "startOffset" : 50,
      "endOffset" : 57
    }, {
      "referenceID" : 19,
      "context" : "physiological dependence and Huntington’s Disease [20-24].",
      "startOffset" : 50,
      "endOffset" : 57
    }, {
      "referenceID" : 20,
      "context" : "physiological dependence and Huntington’s Disease [20-24].",
      "startOffset" : 50,
      "endOffset" : 57
    }, {
      "referenceID" : 21,
      "context" : "physiological dependence and Huntington’s Disease [20-24].",
      "startOffset" : 50,
      "endOffset" : 57
    }, {
      "referenceID" : 3,
      "context" : "8 Three studies assessed the function of ERβ on neurogenesis [6, 25, 26].",
      "startOffset" : 61,
      "endOffset" : 72
    }, {
      "referenceID" : 22,
      "context" : "8 Three studies assessed the function of ERβ on neurogenesis [6, 25, 26].",
      "startOffset" : 61,
      "endOffset" : 72
    }, {
      "referenceID" : 23,
      "context" : "8 Three studies assessed the function of ERβ on neurogenesis [6, 25, 26].",
      "startOffset" : 61,
      "endOffset" : 72
    }, {
      "referenceID" : 7,
      "context" : "Five studies evaluated gene and protein expression [10, 27-30].",
      "startOffset" : 51,
      "endOffset" : 62
    }, {
      "referenceID" : 24,
      "context" : "Five studies evaluated gene and protein expression [10, 27-30].",
      "startOffset" : 51,
      "endOffset" : 62
    }, {
      "referenceID" : 25,
      "context" : "Five studies evaluated gene and protein expression [10, 27-30].",
      "startOffset" : 51,
      "endOffset" : 62
    }, {
      "referenceID" : 26,
      "context" : "Five studies evaluated gene and protein expression [10, 27-30].",
      "startOffset" : 51,
      "endOffset" : 62
    }, {
      "referenceID" : 27,
      "context" : "Five studies evaluated gene and protein expression [10, 27-30].",
      "startOffset" : 51,
      "endOffset" : 62
    }, {
      "referenceID" : 24,
      "context" : "required in order to potentiate mitochondrial function in the brain [27].",
      "startOffset" : 68,
      "endOffset" : 72
    }, {
      "referenceID" : 25,
      "context" : "affects neuronal control of microglia and complement expression.[28].",
      "startOffset" : 64,
      "endOffset" : 68
    }, {
      "referenceID" : 28,
      "context" : "receptor specific binding and found no modulating effect [31].",
      "startOffset" : 57,
      "endOffset" : 61
    }, {
      "referenceID" : 29,
      "context" : "(GABA) transmission and postsynaptic response in GnRH neurons [32].",
      "startOffset" : 62,
      "endOffset" : 66
    }, {
      "referenceID" : 5,
      "context" : "the authors concluded that ERβ may modulate HPA/neuroendocrine stress reactivity [8].",
      "startOffset" : 81,
      "endOffset" : 84
    }, {
      "referenceID" : 30,
      "context" : "response and HPA axis disorders pathogenesis [33].",
      "startOffset" : 45,
      "endOffset" : 49
    }, {
      "referenceID" : 3,
      "context" : "behaviour, was assessed in two studies [6, 34].",
      "startOffset" : 39,
      "endOffset" : 46
    }, {
      "referenceID" : 31,
      "context" : "behaviour, was assessed in two studies [6, 34].",
      "startOffset" : 39,
      "endOffset" : 46
    }, {
      "referenceID" : 31,
      "context" : "ventromedial nucleus averts the action of ERα in the induction of PRs [34], whereas one study reported",
      "startOffset" : 70,
      "endOffset" : 74
    }, {
      "referenceID" : 3,
      "context" : "increased PRs in the murine dorsal raphe nucleus but not in the hippocampus [6].",
      "startOffset" : 76,
      "endOffset" : 79
    }, {
      "referenceID" : 6,
      "context" : "investigated memory as their main outcome [9, 10, 36, 37].",
      "startOffset" : 42,
      "endOffset" : 57
    }, {
      "referenceID" : 7,
      "context" : "investigated memory as their main outcome [9, 10, 36, 37].",
      "startOffset" : 42,
      "endOffset" : 57
    }, {
      "referenceID" : 33,
      "context" : "investigated memory as their main outcome [9, 10, 36, 37].",
      "startOffset" : 42,
      "endOffset" : 57
    }, {
      "referenceID" : 34,
      "context" : "investigated memory as their main outcome [9, 10, 36, 37].",
      "startOffset" : 42,
      "endOffset" : 57
    }, {
      "referenceID" : 7,
      "context" : "Another study [10] concluded that along with increased protein expression of",
      "startOffset" : 14,
      "endOffset" : 18
    }, {
      "referenceID" : 7,
      "context" : "hippocampal synaptic plasticity and improve hippocampus-dependent cognition [10].",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 34,
      "context" : "alterations in monoaminergic containing systems primarily in the prefrontal cortex and hippocampus.[37].",
      "startOffset" : 99,
      "endOffset" : 103
    }, {
      "referenceID" : 6,
      "context" : "improvement in all these outcomes when ERβ agonist (DPN) was given periodically [9].",
      "startOffset" : 80,
      "endOffset" : 83
    }, {
      "referenceID" : 35,
      "context" : "maintaining hippocampal function during aging.[38] The second study on gene and protein expression demonstrated a decrease in apolipoprotein E (ApoE) mRNA protein expression (detrimental in AD) with",
      "startOffset" : 46,
      "endOffset" : 50
    }, {
      "referenceID" : 37,
      "context" : "phosphatidylinositol 3-kinase (PI3-K) [40].",
      "startOffset" : 38,
      "endOffset" : 42
    }, {
      "referenceID" : 6,
      "context" : "considered whether protection against ischemia was conferred either by way of DPN [9, 42] or WAY",
      "startOffset" : 82,
      "endOffset" : 89
    }, {
      "referenceID" : 39,
      "context" : "considered whether protection against ischemia was conferred either by way of DPN [9, 42] or WAY",
      "startOffset" : 82,
      "endOffset" : 89
    }, {
      "referenceID" : 41,
      "context" : "and concluded that ERβ may also confer protection against neuroinflammation [44].",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 43,
      "context" : "suggesting a role of ERβ in the processing of emotional behaviour [46].",
      "startOffset" : 66,
      "endOffset" : 70
    }, {
      "referenceID" : 44,
      "context" : "anxiolytic effects mediated by ERβ [47].",
      "startOffset" : 35,
      "endOffset" : 39
    }, {
      "referenceID" : 3,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 8,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 45,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 46,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 47,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 48,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 49,
      "context" : "12 Seven studies focused on depression-like behaviour [6, 11, 48-52].",
      "startOffset" : 54,
      "endOffset" : 68
    }, {
      "referenceID" : 3,
      "context" : "test or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].",
      "startOffset" : 79,
      "endOffset" : 93
    }, {
      "referenceID" : 8,
      "context" : "test or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].",
      "startOffset" : 79,
      "endOffset" : 93
    }, {
      "referenceID" : 46,
      "context" : "test or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].",
      "startOffset" : 79,
      "endOffset" : 93
    }, {
      "referenceID" : 47,
      "context" : "test or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].",
      "startOffset" : 79,
      "endOffset" : 93
    }, {
      "referenceID" : 48,
      "context" : "test or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].",
      "startOffset" : 79,
      "endOffset" : 93
    }, {
      "referenceID" : 49,
      "context" : "test or forced swim test and found an anti-depressant effect of ERβ activation [6, 11, 49-52].",
      "startOffset" : 79,
      "endOffset" : 93
    }, {
      "referenceID" : 5,
      "context" : "the same conclusion in that both outcomes were decreased after the use of ERβ agonists [8, 53].",
      "startOffset" : 87,
      "endOffset" : 94
    }, {
      "referenceID" : 50,
      "context" : "the same conclusion in that both outcomes were decreased after the use of ERβ agonists [8, 53].",
      "startOffset" : 87,
      "endOffset" : 94
    }, {
      "referenceID" : 52,
      "context" : "maintained by using the selective ERβ agonist, LY3201) even after ovariectomy [55].",
      "startOffset" : 78,
      "endOffset" : 82
    }, {
      "referenceID" : 53,
      "context" : "discrimination and modulation of social behaviour [56, 57].",
      "startOffset" : 50,
      "endOffset" : 58
    }, {
      "referenceID" : 54,
      "context" : "discrimination and modulation of social behaviour [56, 57].",
      "startOffset" : 50,
      "endOffset" : 58
    }, {
      "referenceID" : 57,
      "context" : "fear memory retrieval mechanisms through activation of ERβ [60].",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 58,
      "context" : "Akt and TrkB are markers of hippocampal synaptic plasticity [61].",
      "startOffset" : 60,
      "endOffset" : 64
    }, {
      "referenceID" : 13,
      "context" : "determine the initiation and progression of neurodegenerative disorders [16].",
      "startOffset" : 72,
      "endOffset" : 76
    }, {
      "referenceID" : 10,
      "context" : "essential for the trafficking and clustering of signalling molecules [13].",
      "startOffset" : 69,
      "endOffset" : 73
    }, {
      "referenceID" : 7,
      "context" : "interventions against Huntington’s disease [10, 62].",
      "startOffset" : 43,
      "endOffset" : 51
    }, {
      "referenceID" : 59,
      "context" : "interventions against Huntington’s disease [10, 62].",
      "startOffset" : 43,
      "endOffset" : 51
    }, {
      "referenceID" : 62,
      "context" : "schizophrenia, anxiety and depression [65, 66].",
      "startOffset" : 38,
      "endOffset" : 46
    }, {
      "referenceID" : 63,
      "context" : "schizophrenia, anxiety and depression [65, 66].",
      "startOffset" : 38,
      "endOffset" : 46
    }, {
      "referenceID" : 64,
      "context" : "may prove to be potential opportunities for treatment for Huntington’s disease, AD, epilepsy, and trauma [67, 68].",
      "startOffset" : 105,
      "endOffset" : 113
    }, {
      "referenceID" : 65,
      "context" : "may prove to be potential opportunities for treatment for Huntington’s disease, AD, epilepsy, and trauma [67, 68].",
      "startOffset" : 105,
      "endOffset" : 113
    }, {
      "referenceID" : 66,
      "context" : "Although ERβ is present in many areas of the neocortex, it is highly expressed in the hippocampus and frontal cortex, areas that are important for memory [69].",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 5,
      "context" : "targeting ERβ may be of benefit in the treatment of anorexia nervosa and depression, conditions characterized by dysregulation of the HPA axis [8, 33].",
      "startOffset" : 143,
      "endOffset" : 150
    }, {
      "referenceID" : 30,
      "context" : "targeting ERβ may be of benefit in the treatment of anorexia nervosa and depression, conditions characterized by dysregulation of the HPA axis [8, 33].",
      "startOffset" : 143,
      "endOffset" : 150
    }, {
      "referenceID" : 31,
      "context" : "the expression of progesterone receptors in the hypothalamic ventromedial nucleus [34].",
      "startOffset" : 82,
      "endOffset" : 86
    }, {
      "referenceID" : 3,
      "context" : "order to increase progesterone receptor expression [6].",
      "startOffset" : 51,
      "endOffset" : 54
    }, {
      "referenceID" : 32,
      "context" : "on the co-expression of other estrogen receptors, including ERα [35].",
      "startOffset" : 64,
      "endOffset" : 68
    }, {
      "referenceID" : 35,
      "context" : "sample with low estradiol level, ERβ may compensate to maintain hippocampal function, provided that estradiol level is increased [38, 39, 41].",
      "startOffset" : 129,
      "endOffset" : 141
    }, {
      "referenceID" : 36,
      "context" : "sample with low estradiol level, ERβ may compensate to maintain hippocampal function, provided that estradiol level is increased [38, 39, 41].",
      "startOffset" : 129,
      "endOffset" : 141
    }, {
      "referenceID" : 38,
      "context" : "sample with low estradiol level, ERβ may compensate to maintain hippocampal function, provided that estradiol level is increased [38, 39, 41].",
      "startOffset" : 129,
      "endOffset" : 141
    }, {
      "referenceID" : 37,
      "context" : "rapidly to estradiol administration, may prove to be a target for prevention of AD [40].",
      "startOffset" : 83,
      "endOffset" : 87
    }, {
      "referenceID" : 72,
      "context" : "were found to increase the risk of AD in women.[75]",
      "startOffset" : 47,
      "endOffset" : 51
    }, {
      "referenceID" : 6,
      "context" : "preservation of mitochondrial function [9, 42].",
      "startOffset" : 39,
      "endOffset" : 46
    }, {
      "referenceID" : 39,
      "context" : "preservation of mitochondrial function [9, 42].",
      "startOffset" : 39,
      "endOffset" : 46
    }, {
      "referenceID" : 6,
      "context" : "increased in studying the pathway by which ERβ may potentiate mitochondrial function [9, 27].",
      "startOffset" : 85,
      "endOffset" : 92
    }, {
      "referenceID" : 24,
      "context" : "increased in studying the pathway by which ERβ may potentiate mitochondrial function [9, 27].",
      "startOffset" : 85,
      "endOffset" : 92
    }, {
      "referenceID" : 73,
      "context" : "subclinical states of neurodegeneration and cognitive decline [76].",
      "startOffset" : 62,
      "endOffset" : 66
    }, {
      "referenceID" : 5,
      "context" : "This systematic review also shows consistency in the role of ERβ in modulating estrogen signaling in the process of emotional behaviour [8, 33, 45-47] and other types of behaviour such as social recognition and",
      "startOffset" : 136,
      "endOffset" : 150
    }, {
      "referenceID" : 30,
      "context" : "This systematic review also shows consistency in the role of ERβ in modulating estrogen signaling in the process of emotional behaviour [8, 33, 45-47] and other types of behaviour such as social recognition and",
      "startOffset" : 136,
      "endOffset" : 150
    }, {
      "referenceID" : 42,
      "context" : "This systematic review also shows consistency in the role of ERβ in modulating estrogen signaling in the process of emotional behaviour [8, 33, 45-47] and other types of behaviour such as social recognition and",
      "startOffset" : 136,
      "endOffset" : 150
    }, {
      "referenceID" : 43,
      "context" : "This systematic review also shows consistency in the role of ERβ in modulating estrogen signaling in the process of emotional behaviour [8, 33, 45-47] and other types of behaviour such as social recognition and",
      "startOffset" : 136,
      "endOffset" : 150
    }, {
      "referenceID" : 44,
      "context" : "This systematic review also shows consistency in the role of ERβ in modulating estrogen signaling in the process of emotional behaviour [8, 33, 45-47] and other types of behaviour such as social recognition and",
      "startOffset" : 136,
      "endOffset" : 150
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}